<!--

File produced by pipelineRunner package (for JATS 2 SCJATS with pipeline SCJATS)
At: 2025-05-22T15:12:23.822Z

Version        : 1.16.1
Last update    : 2024-08-27
Modified by    : dunnm

-->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id><journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id><journal-id journal-id-type="publisher-id">databa</journal-id><journal-title-group><journal-title>Database: The Journal of Biological Databases and Curation</journal-title></journal-title-group><issn pub-type="epub">1758-0463</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39879562</article-id><article-id pub-id-type="pmc">PMC11776536</article-id>
<article-id pub-id-type="doi">10.1093/database/baae121</article-id><article-id pub-id-type="publisher-id">baae121</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00960</subject></subj-group></article-categories><title-group><article-title>The TOXIN knowledge graph: supporting animal-free risk assessment of cosmetics</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1023-7987</contrib-id><name><surname>Sepehri</surname><given-names>Sara</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Heymans</surname><given-names>Anja</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Win</surname><given-names>Dinja De</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Maushagen</surname><given-names>Jan</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Sanctorum</surname><given-names>Audrey</given-names></name><aff>
<institution content-type="department">WISE lab, Department of Computer Science, Vrije Universiteit Brussel</institution>, Pleinlaan 9, Brussels 1050, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Debruyne</surname><given-names>Christophe</given-names></name><aff>
<institution content-type="department">Montefiore Institute, University of Li&#x000e8;ge</institution>, All&#x000e9;e de la d&#x000e9;couverte 10, Li&#x000e8;ge 4000, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Rodrigues</surname><given-names>Robim M</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Kock</surname><given-names>Joery De</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Rogiers</surname><given-names>Vera</given-names></name><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author"><name><surname>Troyer</surname><given-names>Olga De</given-names></name><aff>
<institution content-type="department">WISE lab, Department of Computer Science, Vrije Universiteit Brussel</institution>, Pleinlaan 9, Brussels 1050, <country country="BE">Belgium</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6685-7299</contrib-id><name><surname>Vanhaecke</surname><given-names>Tamara</given-names></name><!--Tamara.Vanhaecke@vub.be--><aff>
<institution content-type="department">Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel</institution>, Laarbeeklaan 103, Brussels 1090, <country country="BE">Belgium</country></aff><xref rid="COR0001" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="COR0001">*Corresponding author. Department of In Vitro Toxicology and Dermato-Cosmetology (IVTD), Laarbeeklaan 103, Brussels 1090, Belgium. E-mail: <email xlink:href="Tamara.Vanhaecke@vub.be">Tamara.Vanhaecke@vub.be</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2025-01-28"><day>28</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>1</month><year>2025</year></pub-date><volume>2025</volume><elocation-id>baae121</elocation-id><history><date date-type="received"><day>12</day><month>1</month><year>2024</year></date><date date-type="rev-recd"><day>18</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2024</year></date><date date-type="editorial-decision"><day>19</day><month>11</month><year>2024</year></date><date date-type="corrected-typeset"><day>29</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025. Published by Oxford University Press.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="baae121.pdf"/><abstract><title>Abstract</title><p>The European Union&#x02019;s ban on animal testing for cosmetic products and their ingredients, combined with the lack of validated animal-free methods, poses challenges in evaluating their potential repeated-dose organ toxicity. To address this, innovative strategies like Next-Generation Risk Assessment (NGRA) are being explored, integrating historical animal data with new mechanistic insights from non-animal New Approach Methodologies (NAMs). This paper introduces the TOXIN knowledge graph (TOXIN KG), a tool designed to retrieve toxicological information on cosmetic ingredients, with a focus on liver-related data. TOXIN KG uses graph-structured semantic technology and integrates toxicological data through ontologies, ensuring interoperable representation. The primary data source is safety information on cosmetic ingredients from scientific opinions issued by the Scientific Committee on Consumer Safety between 2009 and 2019. The ToxRTool automates the reliability assessment of toxicity studies, while the Simplified Molecular Input Line Entry System (SMILES) notation standardizes chemical identification, enabling <italic toggle="yes">in silico</italic> prediction of repeated-dose toxicity via the implementation of the Organization for Economic Co-operation and Development Quantitative Structure&#x02013;Activity Relationship Toolbox (OECD QSAR Toolbox). The ToXic Process Ontology, enriched with relevant biological repositories, is employed to represent toxicological concepts systematically. Search filters allow the identification of cosmetic compounds potentially linked to liver toxicity. Data visualization is achieved through Ontodia, a JavaScript library. TOXIN KG, filled with information for 88 cosmetic ingredients, allowed us to identify 53 compounds affecting at least one liver toxicity parameter in a 90-day repeated-dose animal study. For one compound, we illustrate how TOXIN KG links this observation to hepatic cholestasis as an adverse outcome. In an <italic toggle="yes">ab initio</italic> NGRA context, follow-up <italic toggle="yes">in vitro</italic> studies using human-based NAMs would be necessary to understand the compound&#x02019;s biological activity and the molecular mechanism leading to the adverse effect. In summary, TOXIN KG emerges as a valuable tool for advancing the reusability of cosmetics safety data, providing knowledge in support of NAM-based hazard and risk assessments.</p><p>
<bold>Database URL</bold>: <ext-link xlink:href="https://toxin-search.netlify.app/" ext-link-type="uri">https://toxin-search.netlify.app/</ext-link></p></abstract><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Research Chair Mireille Aerens for the development of Alternatives to Animal Testing</institution></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Onderzoeksraad Vrije Universiteit Brussel</institution></institution-wrap>
</funding-source><award-id>IRP19</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Fonds Wetenschappelijk Onderzoek</institution><institution-id institution-id-type="DOI">10.13039/501100003130</institution-id></institution-wrap>
</funding-source><award-id>1276721N</award-id></award-group></funding-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Research Chair Mireille Aerens for the development of Alternatives to Animal Testing</institution></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Onderzoeksraad Vrije Universiteit Brussel</institution></institution-wrap>
</funding-source><award-id>IRP19</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Fonds Wetenschappelijk Onderzoek</institution><institution-id institution-id-type="DOI">10.13039/501100003130</institution-id></institution-wrap>
</funding-source><award-id>1276721N</award-id></award-group></funding-group><counts><page-count count="22"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Since July 2013, Regulation (EC) No. 1223/2009 has been fully enforced for cosmetic products within the European Union (EU). According to Article 3 of this regulation, any cosmetic product introduced to the EU market must be safe for human health under normal or reasonably anticipated conditions of use. To ensure the safety of cosmetic products, the safety of their composing ingredients is controlled via two parallel channels running simultaneously, as depicted in <xref rid="F1" ref-type="fig">Fig.&#x000a0;1</xref>. At the EU level, the Scientific Committee on Consumer Safety (SCCS) evaluates cosmetic ingredients that could raise health concerns. These substances are listed in Annexes II&#x02013;VI, with Annexes II and III serving as &#x0201c;negative lists&#x0201d;&#x02014;List II includes prohibited pharmaceutical substances. At the same time, List III contains restricted substances allowed only for specific uses and concentrations, such as hair dyes. Annexes IV, V, and VI are &#x0201c;positive lists,&#x0201d; including approved colorants, preservatives, and ultraviolet (UV) filters. The SCCS provides comprehensive toxicological reports, known as &#x0201c;Scientific Opinions,&#x0201d; based on industry-prepared dossiers. These reports, which mainly include exposure data and toxicological studies, are used by the Directorate-General for risk management for the Internal Market, Industry, Entrepreneurship, and small and medium enterprises (SMEs) (DG GROW). All SCCS Opinions are publicly accessible through the EU&#x02019;s official health webpage. Concurrently, the industry is responsible for the safety assessment of finished cosmetic products and their ingredients before market entry. Qualified safety assessors compile these assessments and report to the &#x0201c;Responsible Person,&#x0201d; the industry&#x02019;s risk manager.</p><fig position="float" id="F1" fig-type="figure"><label>Figure&#x000a0;1.</label><caption><p>Taken from [<xref rid="R1" ref-type="bibr">1</xref>]. In the EU, cosmetic ingredient safety is ensured through two parallel and simultaneous control channels. Abbreviation: PIF, Product Information File.</p></caption><graphic xlink:href="baae121f1" position="float"/></fig><p>A significant complicating factor in the safety evaluation of cosmetics within the EU is that since March 2013, a total ban on animal testing has been in place [Regulation (EC) No. 1223/2009]. Before this date, a phased series of bans was implemented, starting with prohibiting testing cosmetic products on animals on 11 March 2004. This was succeeded on 11 March 2009, by the cessation of animal tests for all human health effects, except for long-term tests conducted outside the EU. Finally, a total ban for all toxicological endpoints, without any exceptions, was instituted on 11 March 2013. Consequently, only validated replacement alternative methods can be used to assess the safety of cosmetics. Validated replacement alternative methods are available for specific toxicity endpoints (local toxicity), such as skin and eye corrosion/irritation, skin sensitization, and phototoxicity. However, for more complex endpoints such as repeated-dose systemic toxicity, the development of New Approach Methodologies (NAMs) is necessary to replace traditional animal testing and make the transition toward animal-free risk assessment methodology without relying on experimental animals, commonly referred to as Next Generation Risk Assessment (NGRA) [<xref rid="R1" ref-type="bibr">1</xref>].</p><p>Because long-term and complex toxicological responses in living animals cannot be captured using single non-animal methods, it is necessary to combine several test methods for chemical hazard characterization, e.g. Integrated Approaches to Testing and Assessment (IATA). IATAs rely on an integrated analysis of existing information and the generation of new data using non-testing and testing methods. Non-testing methods involve <italic toggle="yes">in silico</italic> techniques like grouping (category formation based on toxicological criteria), read-across (extrapolating information from structural and functional analogs), and quantitative structure&#x02013;activity relationship (QSAR) predictions. In the context of cosmetics, testing methods encompass <italic toggle="yes">in chemico</italic> approaches (providing physicochemical and mechanistic organic chemistry data) and <italic toggle="yes">in vitro</italic> and <italic toggle="yes">ex vivo</italic> methodologies that are preferably human-based and inform on the toxicological mechanisms of the compound under investigation[<xref rid="R2" ref-type="bibr">2&#x02013;4</xref>].</p><p>This paper introduces a usable knowledge graph (KG), where &#x02018;usability&#x02019; refers to the design of the KG to facilitate its use and integration into processes and applications, known as TOXIN knowledge graph (TOXIN KG), to assist in new risk assessment approaches for evaluating the safety of cosmetic ingredients. The developed TOXIN KG is built upon a graph-structured semantic technology, specifically the Resource Description Framework (RDF), and integrates relevant data using ontologies. The primary data source for TOXIN KG comprises existing safety data of annexed cosmetic ingredients, including information from animal studies carried out on cosmetic ingredients before the testing and marketing bans, as presented in SCCS scientific opinions. In addition, <italic toggle="yes">in silico</italic> toxicity predictions are made possible by integrating the OECD QSAR Toolbox into TOXIN KG. Furthermore, TOXIN KG can deduce implicit information from explicit data using rule-based mechanisms, exemplified for liver toxicity.</p></sec><sec id="s2"><title>Methodology</title><p>The development of the TOXIN KG prototype involves three main steps: (I) data gathering, (II) data structuring and input (In computer science, &#x0201c;data ingestion&#x0201d; refers to the process of data input, while in toxicology, the term &#x0201c;ingestion&#x0201d; specifically denotes oral intake. This paper has adopted a neutral term, &#x0201c;data input,&#x0201d; to prevent potential confusion.), and (III) leveraging the tool&#x02019;s functionality (<xref rid="F2" ref-type="fig">Fig.&#x000a0;2</xref>). The data processing workflow begins with the first step, data gathering, which involves collecting SCCS opinions in PDF format. During this phase, opinions not meeting initial criteria&#x02014;specifically, the presence of a repeated dose toxicity (RDT) study and the absence of nano-ingredients&#x02014;are excluded. The second step focuses on structuring the data by providing a framework based on OECD guidelines. This step ensures consistency through input rules and involves capturing and inputting data in a structured manner. As a resource-intensive phase, it relies on human expertise with a fundamental understanding of toxicology. Together, these two steps constitute the data curation phase.The third step prepares the curated data for exploitation by implementing tools for data retrieval, reliability assessment, and structural analysis. This step leverages the functionalities of the TOXIN KG and is closely tied to the data curation steps from the first two stages. It includes tasks such as automatic SMILES generation, automated assessment of toxicological studies using Klimisch scores, retrieving <italic toggle="yes">in silico</italic> HESS predictions for RDT, and utilizing profilers through the OECD QSAR Toolbox for identifying structural alerts and structure&#x02013;activity relationship (SAR)&#x02013;based chemical grouping. To enhance specificity, liver-specific search filters are introduced to refine the data. For improved data accessibility and user experience, Ontodia is employed to create an attractive and user-friendly interface.</p><fig position="float" id="F2" fig-type="figure"><label>Figure&#x000a0;2.</label><caption><p>The development of TOXIN KG follows a structured workflow consisting of three main stages: data gathering, data structuring and ingestion, and leveraging functionality using Semantic Web technologies.</p></caption><graphic xlink:href="baae121f2" position="float"/></fig><sec id="s2-s1"><title>Phase I&#x02014;data curation and transformation to a machine-processable format</title><p>Data curation, as defined by the National Library of Medicine, involves collecting, organizing, managing, and maintaining data to ensure its accuracy, reliability, and usability over time [<xref rid="R5" ref-type="bibr">5</xref>]. For TOXIN KG, this involves the following.</p><sec id="s2-s1-s1"><title>Data gathering</title><p>SCCS opinions from 2009 to 2019 without nano-ingredients and containing 90-day repeated-dose toxicity studies were used as sources [<xref rid="R6" ref-type="bibr">6</xref>]. These 93 opinions cover 88 cosmetic ingredients: 62 hair dyes, 9 preservatives and disinfectants, 5 UV filters, 2 fragrances, 2 solvents, 4 ingredients with multiple applications, and 4 substances with other cosmetic uses (oral hygiene, antiwrinkle, skin lightening, and hair-waving products). Each SCCS opinion details exposure, physicochemical properties, and toxicological studies. The opinions were downloaded in Portable Document Format (PDF) from the official EU health page for analysis [<xref rid="R7" ref-type="bibr">7</xref>].</p><p>The SCCS opinions often use natural language without a controlled vocabulary, posing a challenge for tools like TOXIN KG that rely on structured data. To address this, the Universe of Discourse for TOXIN KG has been meticulously structured at a granular level, facilitating the generation of the KG. Given the complexity and diversity of opinions, domain experts, rather than Artificial Intelligence (AI) technologies such as large language models (LLMs), were involved in interpreting these varied perspectives.</p></sec><sec id="s2-s1-s2"><title>Data structuring and input</title><p>Data were manually entered into Microsoft Excel following predefined rules and the structure of the opinions. Excel was chosen for its simplicity and familiarity among toxicologists, allowing them to capture data without extensive Information Technology (IT) expertise. However, Excel has limitations in handling hierarchical data and large tables directly [<xref rid="R8" ref-type="bibr">8</xref>]. The Excel files were converted to a comma-separated value (CSV) format to facilitate data processing and transformation. CSV serves as an intermediary format that is more coding-friendly before converting the data into RDF. The CSV files were then transformed into RDF graphs using Relational Database (RDB) to RDF Mapping Language (R2RML). R2RML was employed because it is the standard mapping language for converting relational data into RDF. It is suitable for knowledge storage and semantic reasoning, especially in the context of linked data and the Semantic Web [<xref rid="R9" ref-type="bibr">9</xref>]. We adopted the R2RML-F engine for this process, which processes CSV files as in memory for the RDF generation process. This choice facilitates efficient transformation from the CSV format to RDF, leveraging the strengths of R2RML for mapping and the flexibility of the CSV format [<xref rid="R10" ref-type="bibr">10</xref>]. Storing data as RDF ensures interoperability by providing a standardized format that supports data integration and advanced querying. RDF organizes data for machine comprehension, allowing seamless data exchange between systems and improving the overall utility of the information. It also supports semantic applications, enhancing machines&#x02019; capability to reason about data and providing flexibility in data structuring [<xref rid="R11" ref-type="bibr">11</xref>].</p><sec id="s2-s1-s2-s1"><title>Data structuring</title><p>Data organization aligns with OECD guideline testing methods, breaking it into &#x0201c;concepts&#x0201d; and &#x0201c;value properties.&#x0201d; This process, termed &#x0201c;guideline profiling,&#x0201d; involves defining &#x0201c;concepts&#x0201d; as entities without data values that shape the data hierarchy and &#x0201c;value properties&#x0201d; as specific data values. In our data structure, concepts are denoted with capital letters, while value properties are written in lowercase. Initially, profiles were created for acute toxicity, RDT, toxicokinetics, and skin absorption. For example, the data structure for OECD test No. 408 on repeated-dose oral toxicity [<xref rid="R12" ref-type="bibr">12</xref>] (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3</xref>) includes standardized units such as ml/kg body weight (bw) for dose volume, and value types such as YES/NO for the value property &#x0201c;moribund or dead animals prior to study termination&#x0201d; [<xref rid="R13" ref-type="bibr">13</xref>]. This comprehensive structure supports automated Klimisch scoring and liver-specific search filters (see Phase II). The &#x0201c;Reliability&#x0201d; concept, created by the authors, was added to incorporate value properties capturing study credibility. This concept includes elements such as SCCS comments, study year, Good Laboratory Practice (GLP) status, ref. in dossier (links to the study reference mentioned in the opinion), and additional information fields. This structure facilitates future data queries using AI-based Natural Language Processing (NLP) tools.</p><fig position="float" id="F3" fig-type="figure"><label>Figure&#x000a0;3.</label><caption><p>Data structure in TOXIN KG for OECD 408&#x02013;guided RDT assessment, integrating liver-specific parameters, reliability metrics, and automated Klimisch scoring.</p></caption><graphic xlink:href="baae121f3" position="float"/></fig><p>
<xref rid="F3" ref-type="fig">Figure&#x000a0;3</xref> illustrates the data structure utilized in TOXIN KG for assessing RDT in compliance with OECD test guideline No. 408. The structure includes key concepts such as clinical and functional observations, hematology, clinical biochemistry, and pathology in rodents exposed for 90 days. These are organized into three levels of concepts, each starting with a capital letter, and their value properties are aligned with OECD 408 requirements. Liver-specific parameters are integrated through the &#x0201c;hepatocellular effect&#x0201d; concept, which is delineated into specific value properties associated with liver enzymes and other biomarkers used to monitor liver function. For instance, the value property &#x0201c;moribund or dead animals prior to study termination&#x0201d; is mapped to Boolean values (YES/NO), while &#x0201c;mortality rate&#x0201d; provides textual explanations. The &#x0201c;Test animal&#x0201d; concept ensures clear representation by distinguishing numerical age values from their units (days, weeks, months and years). Additionally, the structure incorporates the &#x0201c;Reliability&#x0201d; concept, which includes value properties such as &#x0201c;additional information,&#x0201d; &#x0201c;own comments,&#x0201d; and &#x0201c;ref. in dossier.&#x0201d; These properties enhance data credibility and enable the automated assignment of Klimisch scores, a significant advantage of this data structure. The comprehensive design further supports liver-specific analysis by enabling the extension of liver-specific search filters and facilitating the exploitation of hepatotoxicity data (see Phase II).</p></sec><sec id="s2-s1-s2-s2"><title>Data input</title><p>Initially, toxicology experts entered data into Excel, which was reviewed by another expert for accuracy. Although Excel was easy to use, it had limitations in capturing tables and structuring data hierarchy, leading to potential inconsistencies [<xref rid="R8" ref-type="bibr">8</xref>]. Tables were entered as linear text using specific predefined delimiters. However, Excel provided reliable data backup, making it a secure choice for initial data capture [<xref rid="R14" ref-type="bibr">14</xref>]. During data input, redundant information within a single study, such as repeated mentions of dosages, administration routes, and test substance specifications across different sections, was captured only once in TOXIN KG. This practice minimized unnecessary repetition and ensured a more concise and efficient data representation. <xref rid="F4" ref-type="fig">Figure&#x000a0;4</xref> provides an overview of the number of entries in the Excel files for each toxicological end point and study, regardless of their compliance with OECD guidelines, with human studies integrated to ensure that all relevant data are included in TOXIN KG. For key end points such as acute toxicity, RDT, toxicokinetics, and skin absorption, a detailed and comprehensive data structure was developed. This structure breaks down extensive text values into smaller, specific segments, enabling more effective data retrieval and enhancing the ability to query liver-specific effects and related information. In contrast, a less detailed data structure was implemented for other end points, resulting in larger, unsegmented text values. For ingredients with multiple opinions, data were extracted from various opinions, with conclusions drawn from the most recent one for accuracy. Later on, with LLM advancements, the TOXIN Report Analyzer (<ext-link xlink:href="https://sccs-csv.netlify.app" ext-link-type="uri">https://sccs-csv.netlify.app</ext-link>) using ChatGPT-4 was developed to extract text from SCCS opinions and convert it into tables automatically to speed up the data input process. Note that the generated tables are to be reviewed by experts to ensure accuracy (also see the Data governance section). This hybrid AI-expert approach ensures high-quality, scalable data processing and reproducibility [<xref rid="R15" ref-type="bibr">15</xref>].</p><fig position="float" id="F4" fig-type="figure"><label>Figure&#x000a0;4.</label><caption><p>Overview of entries per toxicological end point and study, highlighting detailed data structures for key end points like repeated dose toxicity.</p></caption><graphic xlink:href="baae121f4" position="float"/></fig></sec></sec></sec><sec id="s2-s2"><title>Data governance</title><p>Transitioning from human text-based data to computer-processable data underscores the crucial need for data accuracy and minimizing errors. The axiom &#x0201c;garbage in, garbage out&#x0201d; highlights the importance of precise data input for quality output. Fu <italic toggle="yes">et&#x000a0;al</italic>. emphasized various dimensions of data governance: data accuracy, completeness, integrity, metadata management, availability, and authorization [<xref rid="R16" ref-type="bibr">16</xref>]. In TOXIN KG, toxicologists oversee data accuracy and completeness, while computer scientists handle metadata management, data availability, and authorization. Both groups share responsibility for data integrity. The quality assurance related to metadata management has been documented elsewhere [<xref rid="R11" ref-type="bibr">11</xref>]. Hence, only the other five remaining aspects are briefly discussed hereunder.</p><sec id="s2-s2-s1"><title>Data accuracy</title><p>Ensuring data accuracy and consistency is vital. Human errors in data reading, transferring, and inputting can compromise accuracy. We followed a rigorous data input process from each opinion, including a data validation step. Random sampling was conducted against the original SCCS opinions as the gold standard to refine this process further. For instance, in the case of repeated-dose toxicity studies, a total of 332 studies, we conducted random reviews on 10% of these studies (32 studies). The data input accuracy percentage was calculated by multiplying the number of correct entries (948) by 100 and dividing it by the total entries (990), resulting in an accuracy rate of 96%. Researchers may tolerate some errors, but tools for automated decision-making demand rigorous data governance to ensure accuracy. A computerized tool is yet to be implemented to verify and quantify data accuracy. To further enhance data accuracy and ensure the reliability of the information stored in the KG, toxicologists can input any comments or inconsistencies they may encounter during the data input phase, labeled as &#x0201c;own comments.&#x0201d; This feature contributes to data provenance by allowing experts to document observations and discrepancies, providing additional context and transparency for future data users.</p></sec><sec id="s2-s2-s2"><title>Data completeness</title><p>Thoroughly capturing SCCS opinions prioritized data completeness. The &#x0201c;additional information&#x0201d; value property was introduced to capture supplementary details not explicitly requested by OECD guidelines. This ensures comprehensive data input and contributes to data provenance. An automated tool is yet to be implemented to verify and quantify data completeness.</p></sec><sec id="s2-s2-s3"><title>Data integrity</title><p>Data integrity ensures accuracy, consistency, and completeness while preventing unauthorized modifications. It involves maintaining data quality and consistency over time [<xref rid="R17" ref-type="bibr">17</xref>]. Physical and logical integrity protects against disruptions, errors, and misuse. Physical integrity safeguards data storage, while logical integrity ensures consistency and security through entity, referential, domain, and user-defined rules. Key traits include completeness, accuracy, consistency, timeliness, and standards compliance. Mitigation includes limiting access, validating data, regular audits, error-detection software, and robust backups [<xref rid="R18" ref-type="bibr">18</xref>]. Human and transfer errors were elaborated on earlier under data accuracy. On the other hand, computer scientists need to tackle other issues endangering data integrity.</p></sec><sec sec-type="data-availability" id="s2-s2-s4"><title>Data availability</title><p>SCCS opinions and integrated data, including TOXIN KG, are publicly accessible. A disclaimer notifies users that not all SCCS opinions are (yet) included in TOXIN KG.</p></sec><sec id="s2-s2-s5"><title>Data authorization</title><p>User access to private and sensitive data is controlled through user privileges and predefined authorization policies. Toxicologists transcribe data but cannot generate RDF. Computer scientists have read-only access to Excel for RDF graph generation and maintain the ontology underlying TOXIN KG.</p></sec></sec><sec id="s2-s3"><title>Phase II&#x02014;data exploitation</title><sec id="s2-s3-s1"><title>Leveraging the functionality of TOXIN KG by using Semantic Web technologies</title><p>Semantic Web technology enhances web content to be more meaningful and machine-understandable, improving information organization, linking, and representation. It adds explicit meaning to web content, enabling sophisticated processing and interpretation. Standardized data formats like ontologies and RDF define relationships between data elements. In predictive toxicology, semantic mapping and ontologies enable data integration, standardize representation, facilitate inference, and support knowledge sharing within the community, enhancing the accuracy and effectiveness of predictive models [<xref rid="R19" ref-type="bibr">19&#x02013;22</xref>]. KGs, built using Semantic Web technology, organize information within a graph-like framework, linking entities (nodes) through relationships (edges). This arrangement enhances data analysis, retrieval, and decision-making capabilities. Integrating data involves amalgamating and streamlining diverse sources to construct a cohesive KG [<xref rid="R23" ref-type="bibr">23</xref>]. The primary data source for TOXIN KG is CSV files derived from the created Excel files and integrated into TOXIN KG using R2RML to ensure uniform and comprehensive integration. To make a thorough, multidata source tool for animal-free cosmetics&#x02019; hazard and risk assessment, we integrate data through semantic mapping, linking individual elements to a common ontology within TOXIN KG. ToXic Process Ontology (TXPO) was selected as the primary ontology structure [<xref rid="R22" ref-type="bibr">22</xref>], part of the Open Biomedical Ontologies Foundry. TXPO includes elements from Uber-anatomy ontology, Cell Ontology, National Center for Biotechnology Information (NCBI), Taxonomy, Chemical Entities of Biological Interest, Gene Ontology (GO), Phenotype and Trait Ontology, Integrating Network Objects with Hierarchies, Ontology of Genes and Genomes, and Disease Ontology [<xref rid="R24" ref-type="bibr">24&#x02013;30</xref>]. TXPO focuses on toxicity mechanisms, particularly hepatotoxic mechanisms, aligning with TOXIN KG&#x02019;s goals [<xref rid="R31" ref-type="bibr">31</xref>]. To enrich TXPO, we integrated ontologies such as GO, GO-Causal Activity Model (GO-CAM), and UniProt for human gene products [<xref rid="R32" ref-type="bibr">32</xref>].</p><p>Additionally, we incorporated biological pathway databases Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome to provide a complete overview of biological processes, including biochemical reactions, substance transport, and gene expression [<xref rid="R33" ref-type="bibr">33&#x02013;37</xref>]. The various datasets and ontologies have been integrated into the TOXIN KG by linking to external resources&#x02019; Internationalized Resource Identifiers (IRIs), resulting in a distributed KG. To maintain traceability and prevent incoherencies, these integrations are stored in separate &#x0201c;named graphs,&#x0201d; allowing users to easily manage and trace the origins of the information [<xref rid="R38" ref-type="bibr">38</xref>]. Sanctorum <italic toggle="yes">et&#x000a0;al</italic>. detailed the automatic data integration approach by comparing labels and IRIs [<xref rid="R39" ref-type="bibr">39</xref>].</p><p>Four extra modules were developed to enhance TOXIN KG&#x02019;s functionalities, focusing on improving the end-user experience through seamless integration of the enriched TXPO ontology.</p><sec id="s2-s3-s1-s1"><title>Addition of SMILES to standardize chemical identification</title><p>Various molecular representations have been developed to accommodate the growing number of chemicals and meet computational needs. SCCS opinions use diverse string representations for cosmetic ingredients, including International Nomenclature of Cosmetic Ingredients (INCI) names, chemical names, trade names, synonyms, Chemical Abstracts Service (CAS) numbers, EC numbers, empirical formulas, and 2D graphics. These need standardization to avoid interoperability issues. SMILES, introduced by Weininger in 1988, provides a flexible and efficient chemical structure notation. We implemented SMILES annotations to ensure consistent representation across datasets, enabling accurate data retrieval and improving interoperability. While SMILES strings for small molecules can be easily written and are theoretically correct, variations can occur in generating SMILES models [<xref rid="R40" ref-type="bibr">40</xref>]. Canonical SMILES, produced through canonicalization algorithms, ensure a unique SMILES identifier [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>]. Including canonical SMILES in TOXIN KG is essential for providing a concise and standardized representation of chemical structures within linked data. Except for two polymer ingredients unsuitable for canonical SMILES notation, canonical SMILES has been manually integrated using sources such as PubChem, ChemSpider, and Cheminfo SMILES generator.</p></sec><sec id="s2-s3-s1-s2"><title>Automatic Klimisch score attribution to evaluate the reliability of studies</title><p>Toxicological studies must be reliable for safety evaluations, regulatory decisions, and public health protection. The Klimisch scoring system, introduced in 1997, assesses study reliability. A score of &#x0201c;1&#x0201d; means &#x0201c;reliable without restriction,&#x0201d; adhering to valid guidelines and often conducted under GLP. A score of &#x0201c;2&#x0201d; means &#x0201c;reliable with restriction,&#x0201d; while scores of &#x0201c;3&#x0201d; and &#x0201c;4&#x0201d; denote &#x0201c;not reliable&#x0201d; and &#x0201c;not assignable&#x0201d; due to flaws or lack of data [<xref rid="R43" ref-type="bibr">43</xref>, <xref rid="R44" ref-type="bibr">44</xref>]. The ToxRTool, an Excel-based application developed by EURL ECVAM, enhances transparency when assigning Klimisch scores. It evaluates studies based on five criteria: (i) test substance identification, (ii) test organism characterization, (iii) study design description, (iv) study result documentation, and (v) design and result plausibility. Each criterion includes &#x0201c;normal&#x0201d; and &#x0201c;red&#x0201d; questions rated as 0 or 1. Achieving categories 1 or 2 requires a score of 1 for &#x0201c;red&#x0201d; questions [<xref rid="R45" ref-type="bibr">45</xref>]. <xref rid="T1" ref-type="table">Table&#x000a0;1</xref> summarizes the ToxRTool criteria and their classification. We developed a JavaScript tool for Klimisch category assignment in TOXIN KG, focusing on OECD-compliant studies for acute and repeated-dose toxicity. Accurate Klimisch scoring relies on a comprehensive data structure to locate ToxRTool answers within TOXIN KG. For instance, to evaluate the question &#x0201c;Are sufficient details of the administration scheme given to judge the study?&#x0201d; (criteria Group iii, Question 6), essential details like dilution in diet, total volume applied, and media homogeneity must be retrieved. For the 90-day repeated oral toxicity test (OECD No. 408), the tool scans for &#x0201c;Test method: Test condition: Oral administration: gavage.&#x0201d; If found, it examines &#x0201c;Test method: Test substance: homogeneity and stability&#x0201d; or &#x0201c;Test method: Test condition: dose-volume ml/kg bw&#x0201d; (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3</xref>). This example highlights the detailed data structure designed following OECD guideline profiling, demonstrating the value added by this approach, as shown in <xref rid="F3" ref-type="fig">Fig.&#x000a0;3</xref>. If the test substance is administered through diet or drinking water, the tool focuses on homogeneity and stability data, assigning a score of 0 or 1. For data related to positive and negative control groups (criteria Group iii, Question 4), the &#x0201c;Reliability&#x0201d; structure includes a &#x0201c;control group &#x00026; recovery group&#x0201d; data block. This demonstrates the advantage of adding the &#x0201c;Reliability&#x0201d; concept by the authors&#x02014;the tool checks for the presence of data here. If absent, it examines the dose level data for a &#x0201c;0&#x0201d; dose level representing the negative control. Studies following OECD guidelines generally expect Klimisch scores of 1 or 2, based on adherence to guidelines and GLP compliance. Some studies might omit properties like exposure duration and administration scheme. Therefore, we introduced default values to assume that missing details do not indicate non-compliance but are unintentional omissions. For OECD No. 408 (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3</xref>), default values include &#x0201c;repeated administration scheme&#x0201d; (assumed &#x0201c;7 days/week&#x0201d;) and &#x0201c;duration of exposure&#x0201d; (assumed &#x0201c;90 days&#x0201d;). These assumptions enable efficient evaluation of OECD-compliant studies and prevent erroneous 0 scores for red criteria questions.</p><table-wrap position="float" id="T1"><label>Table&#x000a0;1.</label><caption><p>ToxRTool criteria and questions for Klimisch score grading</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Criteria</th><th valign="bottom" align="left" rowspan="1" colspan="1">Questions</th><th valign="bottom" align="left" rowspan="1" colspan="1">Type of Questions (N: normal, R: red)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">I: Test substance identification</td><td align="left" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Was the test substance identified?</p></list-item><list-item><p>Is the purity of the substance given?</p></list-item><list-item><p>Is information on the source/origin of the substance given?</p></list-item><list-item><p>Is all information on the nature and/or physico-chemical properties of the test item given, which you deem indispensable for judging the data?</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; N</p></list-item><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">II: Test organism characterization</td><td align="left" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Is the species given?</p></list-item><list-item><p>Is the sex of the test organism given?</p></list-item><list-item><p>Is information given on the strain of test animal plus, if considered necessary to judge the study, other specifications?</p></list-item><list-item><p>Is age or body weight of the test organisms at the start of the study given?</p></list-item><list-item><p>For repeated dose toxicity studies only: Is information given on the housing or feeding conditions?</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; N</p></list-item><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">III: Study design description</td><td align="left" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Is the administration route given?</p></list-item><list-item><p>Are doses administered or concentrations in application media given?</p></list-item><list-item><p>Are frequency and duration of exposure as well as time-points of observations explained?</p></list-item><list-item><p>Were negative and positive controls included?</p></list-item><list-item><p>Is the number of animals per group given?</p></list-item><list-item><p>Are sufficient details of the administration scheme given to judge the study?</p></list-item><list-item><p>For inhalation studies and repeated dose toxicity studies only: Were achieved concentrations analytically verified or was stability of the test substance otherwise ensured is made plausible?</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; R</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; R</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">IV: Study results documentation</td><td align="left" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Are the study endpoint(s) and their method(s) of determination clearly described?</p></list-item><list-item><p>Is the description of the study results for all endpoints investigated transparent and complete?</p></list-item><list-item><p>Are the statistical methods applied for data analysis given and applied in a transparent manner?</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list>
&#x000a0;<list list-type="simple"><list-item><p>&#x02013; N</p></list-item></list></td></tr><tr><td align="left" rowspan="1" colspan="1">V: Plausibility of study design and results</td><td align="left" rowspan="1" colspan="1">
<list list-type="order"><list-item><p>Is the study design chosen appropriate for obtaining the substance-specific data aimed at?</p></list-item><list-item><p>Are the quantitative study results reliable?</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>&#x02013; R</p></list-item><list-item><p>&#x02013; N</p></list-item></list>
</td></tr></tbody></table><table-wrap-foot><fn id="T0001-fn1"><p>The five sets of criteria and their corresponding questions in the ToxRTool are presented. The third column specifies the weight assigned to each question, categorized as either &#x0201c;normal&#x0201d; (N) or &#x0201c;red&#x0201d; (R). To achieve reliability categories 1 or 2, questions marked as &#x0201c;Red&#x0201d; must be scored as 1.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-s3-s1-s3"><title>Integration of OECD QSAR Toolbox profilers</title><p>In IATAs, <italic toggle="yes">in silico</italic> methods are indispensable for evaluating chemical toxicity. These methods connect chemical activity/properties with structural characteristics to predict activity data or physicochemical attributes. They also identify structural components influencing these properties within a mechanistic framework. In regulatory contexts, the credibility of <italic toggle="yes">in silico</italic> predictions is enhanced when integrated into a broader Weight-of-Evidence strategy, supported by other information like human-based <italic toggle="yes">in vitro</italic> data [<xref rid="R46" ref-type="bibr">46</xref>].</p><p>The QSAR Toolbox, developed by the OECD, is crucial for chemical hazard assessment [<xref rid="R47" ref-type="bibr">47</xref>]. It uses the (Quantitative) Structure&#x02013;Activity Relationship/Structure&#x02013;Property Relationship [(Q)SAR/SPR] methodology to predict chemical behavior by examining structural attributes and biological activities [<xref rid="R48" ref-type="bibr">48</xref>]. This toolbox includes software programs to profile, categorize, and address data gaps via (Q)SAR/SPR models and read-across techniques for different toxicological endpoints. The QSAR Toolbox encompasses 70 profilers in six groups: predefined, general mechanistic, endpoint&#x02013;specific, empiric, toxicological, and custom. Metabolism profiling includes documented metabolism (400 observed pathways) and simulated metabolism, predicting the metabolic fate of target ingredients [<xref rid="R49" ref-type="bibr">49</xref>]. All these profilers are accessible within TOXIN KG by integrating the Application Programming Interface (API) of the QSAR Toolbox. The key profilers implemented in TOXIN KG are elaborated further.</p><sec id="s2-s3-s1-s3-s1"><title>Hazard Evaluation Support System</title><p>Hazard Evaluation Support System (HESS), in the toxicological profiler category, is relevant for repeated-dose liver toxicity. Developed by Japanese institutions and universities, it categorizes mechanistic insights into <italic toggle="yes">in vivo</italic> RDT for 500 chemicals, defining 33 categories across 14 toxicity types, including hepatotoxicity. Predictions are ranked based on the availability of toxicity mechanism information and a well-defined structural boundary [<xref rid="R50" ref-type="bibr">50</xref>]. Rankings are as follows:</p><p>&#x0201c;A&#x0201d;: Mechanism information present, clear structural boundary, reliable data gap filling.</p><p>&#x0201c;B&#x0201d;: Mechanism information present, unclear structural boundary, limited data gap filling.</p><p>&#x0201c;C&#x0201d;: No mechanism information, empirical tendency, potential for improvement.</p></sec><sec id="s2-s3-s1-s3-s2"><title>Extended Cramer toxic hazard classification</title><p>In the general mechanistic category, the Cramer classification system, a structural classification system, typically assigns chemicals to three classes (I, II, and III) based on their anticipated levels of oral systemic toxicity. However, as recognized by the SCCS, this system is simplified into two classes by combining Classes II and III. This two-class system underpins the Threshold of Toxicological Concern (TTC) concept, primarily applicable to small quantities of chemicals, with exposure thresholds defined by the SCCS [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R52" ref-type="bibr">52</xref>]. Chemicals with exposures below these TTC values pose a low risk of adverse health effects [<xref rid="R53" ref-type="bibr">53</xref>].</p></sec><sec id="s2-s3-s1-s3-s3"><title>Documented and simulated metabolism profiler</title><p>This profiler provides pathways observed in mammals and simulations of <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> rat metabolism and skin metabolism. The skin metabolism simulator mimics mammalian liver metabolism [<xref rid="R54" ref-type="bibr">54</xref>].</p><p>It is important to note that the profilers provided in the QSAR Toolbox are not (Q)SAR models and have not undergone stringent validation to define applicability domains. Recent studies on profiler performance indicate limitations, showing that they may perform poor in predicting specific toxicological endpoints when tested against large datasets [<xref rid="R55" ref-type="bibr">55</xref>]. Therefore, in TOXIN KG, these profilers are used as an initial screening tool to identify potential toxicological alerts. For instance, for RDT, HESS predictions apply a similarity-based measurement focused on selected molecular features of the target chemical [<xref rid="R56" ref-type="bibr">56</xref>]. If the target chemical shows 50% structural similarity based on the Dice measure, it is assigned to the relevant toxicity alert. Thus, predictions from the OECD QSAR Toolbox API in TOXIN KG are only preliminary indicators rather than definitive toxicological assessments, which require a combination of more than one valid QSAR model and/or experimental validation.</p></sec></sec><sec id="s2-s3-s1-s4"><title>Extended liver-specific filters for improved identification of hepatotoxicants</title><p>Although cosmetics are mainly for dermal application, the liver is the primary target organ after repeated oral exposure in laboratory animals [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R57" ref-type="bibr">57</xref>]. However, translating animal model findings to human outcomes is often flawed, as shown by drugs causing liver problems leading to market withdrawal [<xref rid="R58" ref-type="bibr">58&#x02013;60</xref>]. Therefore, it is crucial to assess the human relevance of these observations using human-based NAMs. As a case study, we selected parameters based on literature and OECD guidelines for evaluating liver function disturbances. These include liver tissue damage through necropsy and histopathology, enzymatic changes [Alanine aminotransferase (ALT) (EC 2.6.1.2), aspartate aminotransferase (AST) (EC 2.6.1.1), alkaline phosphatase (ALP) (EC 3.1.3.1), gamma-glutamyl transpeptidase (GGT) (EC 2.3.2.1), sorbitol dehydrogenase (EC 1.1.1.14)], and biomarkers (total bilirubin, total cholesterol, fasting triglycerides, high-density lipoprotein, low-density lipoprotein, total protein, and albumin). These liver-specific search filters help identify cosmetics that may cause liver toxicity by highlighting observed harmful effects. The filters&#x02019; functionality is detailed in the Results and discussion section.</p></sec><sec id="s2-s3-s1-s5"><title>Enhancing data visualization and exploration via Ontodia</title><p>Efficient data presentation is essential for both human understanding and machine analysis. Humans and computers use different methods to grasp and establish connections within data. While text-based representation suffices for human comprehension, forming relationships between various entities can be challenging [<xref rid="R30" ref-type="bibr">30&#x02013;33</xref>]. Graph databases offer an appealing solution to address the complexity of data understanding and interlinking, especially for computer processing. They provide superior query performance and flexibility, making them ideal for managing complex data. Ontodia (We have used a precompiled distribution of Ontodia that was made available on JSFiddle (<ext-link xlink:href="https://jsfiddle.net/yn9ur13h/" ext-link-type="uri">https://jsfiddle.net/yn9ur13h/</ext-link>). This version, namely, 0.8.0, is hosted at <ext-link xlink:href="https://unpkg.com/ontodia@0.8.0/dist/ontodia-full.min.js" ext-link-type="uri">https://unpkg.com/ontodia@0.8.0/dist/ontodia-full.min.js</ext-link>.) is a powerful tool for data representation [<xref rid="R61" ref-type="bibr">61</xref>]. It allows end-users to visualize and seamlessly explore graph data by interacting with RDF graphs [<xref rid="R62" ref-type="bibr">62</xref>]. In TOXIN KG, Ontodia&#x02019;s utility is evident at two levels: at the information level through observations reported in the opinions and at the relationship level. The former links the same observations in TOXIN KG&#x02019;s internal data, while the latter allows more profound indirect linkage between internal and linked data. Both levels are explained and illustrated in the &#x0201c;TOXIN KG links observations to toxicological mechanisms through ontologies&#x0201d; section. Ontodia significantly enhances data visualization and exploration within TOXIN KG, facilitating a comprehensive understanding and streamlined navigation of intricate information. Tools like Ontodia are &#x0201c;unaware&#x0201d; of the application domain; they only recognize that the KG encodes data using RDF and interacts with RDF via the SPARQL query language, another Semantic Web standard. The integration of Ontodia shows that end-users can engage with RDF in different ways and that using open standards facilitates the integration and development of tools on top of the KG.</p></sec></sec></sec></sec><sec id="s3"><title>Results and discussion</title><p>The SCCS has issued scientific opinions since 1979, adapting their format and content to meet evolving legal requirements and scientific advances. On the EU health webpage, the opinions are organized by changes in the committee&#x02019;s name: before October 2004 (&#x0201c;Scientific Committee on Cosmetology&#x0201d; and &#x0201c;Scientific Committee on Cosmetic Products and Non-Food Products&#x0201d;), October 2004 to March 2009 (&#x0201c;Scientific Committee on Consumer Products&#x0201d;), and April 2009 to March 2013, April 2013 to March 2016, April 2016 to December 2021, and beyond (&#x0201c;SCCS&#x0201d;). To enhance machine processability and simplify data organization, we classified the opinions into three periods, focusing on the 2009&#x02013;19 period for creating the TOXIN KG (<xref rid="F4" ref-type="fig">Fig.&#x000a0;4</xref>). Despite 220 opinions evaluating 163 chemicals within this timeframe, TOXIN KG development focused on 93 opinions on 88 cosmetic ingredients, excluding nanoingredients and including 90-day repeated-dose toxicity studies [<xref rid="R6" ref-type="bibr">6</xref>]. This limited dataset does not impede TOXIN KG&#x02019;s development but presents an opportunity for expansion.</p><sec id="s3-s1"><title>Retrieving annexed cosmetic compound data with TOXIN KG</title><p>The user interface of TOXIN KG is designed according to user interface design principles to ensure human understandability [<xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R64" ref-type="bibr">64</xref>]. It offers functions to search and retrieve safety information about annexed cosmetic ingredients using CAS numbers, INCI names, or SMILES notations. The &#x0201c;Chemical compound&#x0201d; search option in TOXIN KG&#x02019;s interface includes the OECD QSAR Toolbox profilers, providing insights into <italic toggle="yes">in silico</italic>-based hazard and metabolite predictions. <xref rid="F5" ref-type="fig">Figure&#x000a0;5</xref> shows the search results for &#x0201c;Basic Yellow 57&#x0201d; (CAS: 68391-31-1) and SMILES, providing detailed information about the chemical, including its identity, physicochemical properties, and intended use. Users can search for specific compounds using various identifiers, such as CAS number, INCI name, and SMILES. TOXIN KG integrates 70 OECD QSAR Toolbox profilers, with a focus on three particularly relevant to systemic and organ toxicity, which are accessible directly on the result page for convenient and efficient information retrieval [<xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R66" ref-type="bibr">66</xref>].</p><fig position="float" id="F5" fig-type="figure"><label>Figure&#x000a0;5.</label><caption><p>Search results for Basic Yellow 57 in TOXIN KG, providing detailed chemical information and access to 70 OECD QSAR Toolbox profilers for systemic and organ toxicity.</p></caption><graphic xlink:href="baae121f5" position="float"/></fig><p>Switching the search function to &#x0201c;health effect&#x0201d; allows users to find compounds associated with specific toxicological effects. Results can be viewed in three formats: compound, opinion, or OECD. The compound view focuses on specific compounds, while the OECD view presents results per test guidelines. Maintaining uniform and standardized ingredient names is crucial for data retrieval. The EU health webpage shows slight variations in ingredient names, such as &#x0201c;HC Blue 15&#x0201d; appearing as &#x0201c;HC Blue No. 15&#x0201d; and &#x0201c;HC Blue No.15.&#x0201d; Such inconsistencies could lead to errors during data retrieval when using strict string matching. Alternative matching methods, like hard-set and proportional thresholds, offer solutions. Hard-set thresholds retain entities meeting specific criteria (e.g. &#x0201c;95% similarity&#x0201d;), while proportional thresholds retain a percentage of the best-performing entities regardless of absolute similarity. In TOXIN KG, proportional searching is in place; for instance, searching &#x0201c;yellow&#x0201d; will display every ingredient with &#x0201c;yellow&#x0201d; in its name [<xref rid="R67" ref-type="bibr">67</xref>]. In the first dataset, TOXIN KG addressed naming inconsistencies by manually incorporating canonical SMILES. Future developments will employ automatic SMILES generation and include data from remaining SCCS opinions. We propose a scalable method prioritizing precision over recall for evaluating correspondence between graphs [<xref rid="R68" ref-type="bibr">68&#x02013;71</xref>].</p></sec><sec id="s3-s2"><title>Automatic attribution of Klimisch scores to acute and repeated-dose toxicity studies</title><p>Data must be readily available in the system to create an automated scoring tool. Non-OECD studies present challenges due to documentation and study design issues. While SCCS comments are integrated into TOXIN KG&#x02019;s reliability assessment part, the tool still needs to interpret these comments in text format. Therefore, the Klimisch scoring tool focuses solely on OECD-compliant studies, covering acute and RDT. To view the automatically scored studies, one can select either &#x0201c;acute toxicity&#x0201d; or &#x0201c;repeated-dose toxicity&#x0201d; under the &#x0201c;health effect&#x0201d; category and click &#x0201c;Go.&#x0201d; This will display a list of all studies related to the selected endpoint. Choosing the &#x0201c;OECD view&#x0201d; groups the studies according to their guideline.</p><p>The ToxRTool calculates the initial category based on numerical points: a sum of 18 or higher falls into Category 1, 13 or higher belongs to Category 2, and &#x0003c;13 is Category 3. For the revised category, red criteria questions are first considered (<xref rid="T1" ref-type="table">Table&#x000a0;1</xref>). If all red criteria score 1, the study is Category 1; if not, it is Category 2 or 3, depending on the sum of points. Our tool uses the same reasoning as the ToxRTool. <xref rid="F6" ref-type="fig">Figure&#x000a0;6</xref> demonstrates the automated Klimisch scoring of an OECD 408 study for Basic Yellow 57, presenting the &#x0201c;sum,&#x0201d; &#x0201c;initial category,&#x0201d; &#x0201c;revised category,&#x0201d; and individual criteria scores. Users can access individual criteria scores by clicking on them for a detailed examination, with SCCS opinion data shown in black and default values in green within the TOXIN KG environment. In this instance, the tool assumes a repeated administration scheme of 7&#x02009;days/week, which is necessary to assign a score of 1 to Criteria (iii), Question 3 concerning exposure frequency.</p><fig position="float" id="F6" fig-type="figure"><label>Figure&#x000a0;6.</label><caption><p>Automated Klimisch scoring of an OECD 408 study for Basic Yellow 57, showing total scores, categories, and individual criteria.</p></caption><graphic xlink:href="baae121f6" position="float"/></fig><p>Including default values and compensating for missing critical attributes in the red criteria questions have proven to be practical in categorizing OECD-compliant studies as 1 or 2. Scoring studies using the automatic Klimisch system is complex due to limited detailed information in the opinions. An accuracy review was conducted by randomly selecting 20 out of 196 studies and comparing the automated scores with manual Klimisch scoring performed by domain experts. The initial accuracy was imperfect, leading to refined data pathways and better mimicking human scoring processes. This exercise highlighted the necessity of incorporating default values to ensure that critical attributes, particularly in red criteria questions, are appropriately addressed, thereby enhancing the accuracy of categorizing OECD-compliant studies into Category 1 or 2. Default values are based on the assumption that the study follows the guidelines. However, vital data, like the sex of animals, are sometimes buried within toxic effect descriptions. This is critical for determining Category 1 or 2 in the Klimisch scoring system. Despite these improvements, some challenges remain. For ingredients with comprehensive opinions, information like batch number or purity, initially stated in physicochemical properties, is not reiterated in the study report and is thus unavailable to the automatic scoring tool. To address this, default values are used to bridge information gaps. However, applying NLP techniques and LLMs could provide a more robust solution. NLP and LLM could automatically extract and interpret critical data points from the text, allowing for a more precise Klimisch scoring process. The challenge is greater for non-OECD studies. The absence of specific information affects the evaluation of all criteria, relying more on expert judgment. Although SCCS comments on these studies are available within TOXIN KG, NLP is essential to interpret these comments and assign Klimisch scores, ensuring a thorough and standardized evaluation of non-OECD studies.</p></sec><sec id="s3-s3"><title>TOXIN KG identifies potential liver toxicants</title><p>To test the performance of the extended liver-specific search filters in TOXIN KG for querying potential liver toxicants, we manually screened the 93 opinions accounting for 88 different cosmetic ingredients for compound-induced changes in liver-related parameters in 90-day RDT studies. This analysis indicated that 53 ingredients altered at least one parameter possibly associated with liver toxicity in animals. <xref rid="T2" ref-type="table">Table&#x000a0;2</xref> lists these 53 ingredients, their respective altered parameters, and their functions. However, replicating these results by a computer using extended filters is more complex. Navigating a knowledge base in toxicology presents challenges due to variations in terminologies used by different experts but with similar meanings. Traditional query systems that rely on keyword-based searches or structured query languages need help capturing these intricacies. We can identify three distinct forms of language complexity within the opinions. The SCCS employs terms like &#x0201c;similar to&#x0201d; and &#x0201c;comparable to&#x0201d; when assessing the likeness of a non-OECD study to an OECD guideline, creating ambiguity.</p><table-wrap position="float" id="T2" orientation="landscape"><label>Table&#x000a0;2.</label><caption><p>The manually compiled Excel table, listing 53 potential liver toxicants from the first dataset of TOXIN KG</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">&#x000a0;</th><th valign="bottom" align="left" rowspan="1" colspan="1">&#x000a0;</th><th valign="bottom" colspan="11" align="center" rowspan="1">Effects</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">&#x000a0;</th><th valign="bottom" align="left" rowspan="1" colspan="1">&#x000a0;</th><th valign="bottom" colspan="11" align="center" rowspan="1">
<italic toggle="yes">In vivo</italic>
</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Cosmetic compound</th><th valign="bottom" align="left" rowspan="1" colspan="1">Function</th><th valign="bottom" align="left" rowspan="1" colspan="1">Cholesterol</th><th valign="bottom" align="left" rowspan="1" colspan="1">Triglycerides</th><th valign="bottom" align="left" rowspan="1" colspan="1">ALT</th><th valign="bottom" align="left" rowspan="1" colspan="1">AST</th><th valign="bottom" align="left" rowspan="1" colspan="1">Phospholipids</th><th valign="bottom" align="left" rowspan="1" colspan="1">Hepatic fat</th><th valign="bottom" align="left" rowspan="1" colspan="1">Hepatocellular hypertrophy</th><th valign="bottom" align="left" rowspan="1" colspan="1">Bilirubin</th><th valign="bottom" align="left" rowspan="1" colspan="1">GGT</th><th valign="bottom" align="left" rowspan="1" colspan="1">ALP</th><th valign="bottom" align="left" rowspan="1" colspan="1">Hepatic necrosis</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">5-Amino-6-chloro-<italic toggle="yes">o</italic>-cresol</td><td align="left" rowspan="1" colspan="1">Precursor for hair dyeing products</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Acetylated vetiver oil&#x02014;AVO&#x02009;=&#x02009;vetiveryl acetate</td><td align="left" rowspan="1" colspan="1">Fragrance</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic Brown 17</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic Red 51</td><td align="left" rowspan="1" colspan="1">Hair dye</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase /decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic violet 2</td><td align="left" rowspan="1" colspan="1">Hair coloring agent</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Bis</italic>(butylbenzoate) diaminotriazine aminopropyltrisiloxane</td><td align="left" rowspan="1" colspan="1">UV filter</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Different<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1">Different<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Butylphenyl methylpropional</td><td align="left" rowspan="1" colspan="1">Fragrance</td><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase (non-OECD)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase (non-OECD)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase (non- OECD)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cetylpyridinium chloride</td><td align="left" rowspan="1" colspan="1">Desinfectant</td><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Decamethylcyclopentasiloxane (cyclopentasiloxane, D5)</td><td align="left" rowspan="1" colspan="1">Antistatic, emollient, humectant, solvent, viscosity controlling, and hair conditioning</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase (inhalation)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ecoG+&#x02009;</td><td align="left" rowspan="1" colspan="1">Preservative, packaging</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC blue No. 15</td><td align="left" rowspan="1" colspan="1">Dye</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC yellow No. 13</td><td align="left" rowspan="1" colspan="1">Hair coloring agent</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hydroxyethyl-2-nitro-<italic toggle="yes">p</italic>-toluidine</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hydroxyethyl-3,4-methylenedioxyaniline HCl</td><td align="left" rowspan="1" colspan="1">Oxidative hair dye</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hydroxyethyl-<italic toggle="yes">p</italic>-phenylenediamine sulfate</td><td align="left" rowspan="1" colspan="1">Oxidative hair coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Hydroxypropyl <italic toggle="yes">p</italic>-phenylenediamine and its dihydrochloride salt (A165)</td><td align="left" rowspan="1" colspan="1">Oxidative agent</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Methylimidazoliumpropyl <italic toggle="yes">p</italic>-phenylenediamine HCl (A166)</td><td align="left" rowspan="1" colspan="1">Oxidative agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>'-<italic toggle="yes">Bis</italic>-(2-hydroxyethyl)-2-nitro-<italic toggle="yes">p</italic>-phenylenediamine</td><td align="left" rowspan="1" colspan="1">Hair dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>-Methyl-2-pyrrolidone</td><td align="left" rowspan="1" colspan="1">Solvent and surfactant</td><td align="left" rowspan="1" colspan="1">Increase/decrease<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">o</italic>-Aminophenol</td><td align="left" rowspan="1" colspan="1">Oxidative agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Different</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Phenoxyethanol</td><td align="left" rowspan="1" colspan="1">Preservative</td><td align="left" rowspan="1" colspan="1">Decrease/increase</td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref><sup>,</sup><xref rid="T0002-fn5" ref-type="table-fn"><sup>&#x000a7;</sup></xref></td><td align="left" rowspan="1" colspan="1">Decrease<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref><sup>,</sup><xref rid="T0002-fn5" ref-type="table-fn"><sup>&#x000a7;</sup></xref></td><td align="left" rowspan="1" colspan="1">Decrease/increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Toluene-2,5-diamine and its sulfate (COLIPA No. A5)</td><td align="left" rowspan="1" colspan="1">Oxidative hair coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">1-Hexyl 4,5-diamino pyrazole sulfate</td><td align="left" rowspan="1" colspan="1">Oxidative hair coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2,6-Dihydroxyethylaminotoluene</td><td align="left" rowspan="1" colspan="1">Precursor for hair colors</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2,7-Naphthalenediol</td><td align="left" rowspan="1" colspan="1">Hair dye formulation</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td></tr><tr><td align="left" rowspan="1" colspan="1">Citric acid (and) silver citrate</td><td align="left" rowspan="1" colspan="1">Preservative</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diethylene glycol monoethyl ether</td><td align="left" rowspan="1" colspan="1">Solvent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (S87)</td><td align="left" rowspan="1" colspan="1">UV filter</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Triclosan</td><td align="left" rowspan="1" colspan="1">Antibacterial</td><td align="left" rowspan="1" colspan="1">Increase (also<xref rid="T0002-fn6" ref-type="table-fn"><sup>|</sup></xref>)/decrease</td><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase/decrease<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease<xref rid="T0002-fn6" ref-type="table-fn"><sup>|</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1">Increase/decrease</td><td align="left" rowspan="1" colspan="1">Increase</td></tr><tr><td align="left" rowspan="1" colspan="1">Disperse black 9</td><td align="left" rowspan="1" colspan="1">Coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC red No.13</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Disperse blue 377</td><td align="left" rowspan="1" colspan="1">Hair dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref><sup>,</sup><xref rid="T0002-fn5" ref-type="table-fn"><sup>&#x000a7;</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Polysilicone-15</td><td align="left" rowspan="1" colspan="1">UV filter</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease <xref rid="T0002-fn9" ref-type="table-fn"><sup>i</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease <xref rid="T0002-fn9" ref-type="table-fn"><sup>i</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease <xref rid="T0002-fn9" ref-type="table-fn"><sup>i</sup></xref></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">o</italic>-Phenylphenol, sodium <italic toggle="yes">o</italic>-phenylphenate, and potassium <italic toggle="yes">o</italic>-phenylphenate</td><td align="left" rowspan="1" colspan="1">Preservative</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease<xref rid="T0002-fn8" ref-type="table-fn"><sup>&#x02016;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic yellow 57</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC red No. 7</td><td align="left" rowspan="1" colspan="1">Hair dye</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">2-Hydroxyethylamino-5-nitroanisole</td><td align="left" rowspan="1" colspan="1">Semi-permanent hair dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Change<xref rid="T0002-fn7" ref-type="table-fn"><sup>&#x000b6;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Acid orange 7</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn2" ref-type="table-fn"><sup>*</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic red 76</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">1,2,4-Trihydroxybenzene</td><td align="left" rowspan="1" colspan="1">Coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn7" ref-type="table-fn"><sup>&#x000b6;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic yellow 87</td><td align="left" rowspan="1" colspan="1">Dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2,6-Diamino-3-((pyridin-3-yl)azo)pyridine</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1">Altered</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Altered</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2-Amino-4-hydroxyethylaminoanisole sulfate</td><td align="left" rowspan="1" colspan="1">Oxidative hair dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2-Amino-5-ethylphenol HCl</td><td align="left" rowspan="1" colspan="1">Oxidative hair coloring agent precursor</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC yellow No. 9</td><td align="left" rowspan="1" colspan="1">Hair coloring</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin a</td><td align="left" rowspan="1" colspan="1">Antiwrinkle</td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn6" ref-type="table-fn"><sup>|</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Zinc pyrithione</td><td align="left" rowspan="1" colspan="1">Preservative</td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn5" ref-type="table-fn"><sup>&#x000a7;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC orange No. 6</td><td align="left" rowspan="1" colspan="1">Hair colorign agent</td><td align="left" rowspan="1" colspan="1">Increase</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Basic orange 31</td><td align="left" rowspan="1" colspan="1">Hair dye</td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn4" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn4" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn4" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Acid red 92</td><td align="left" rowspan="1" colspan="1">Direct dye</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Disperse violet 1</td><td align="left" rowspan="1" colspan="1">Coloring agent</td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn3" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td align="left" rowspan="1" colspan="1">Increase<xref rid="T0002-fn3" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Acid black 1</td><td align="left" rowspan="1" colspan="1">Coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HC blue No. 14</td><td align="left" rowspan="1" colspan="1">Coloring agent</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Decrease</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="T0002-fn1"><p>The table also provides insights into the functions and <italic toggle="yes">in vivo</italic> effects related to liver parameters. It is important to note that the outcomes of these studies may exhibit contradictions due to various factors, such as differences in study design, sample size, methodology, or chance variations.</p></fn><fn id="T0002-fn2"><label>*</label><p>Doubtful or not related to the test compound.</p></fn><fn id="T0002-fn3"><label>&#x02020;</label><p>Not supported histopathologically.</p></fn><fn id="T0002-fn4"><label>&#x02021;</label><p>Incidental.</p></fn><fn id="T0002-fn5"><label>&#x000a7;</label><p>Dermal.</p></fn><fn id="T0002-fn6"><label>|</label><p>Human.</p></fn><fn id="T0002-fn7"><label>&#x000b6;</label><p>Interference with the methodology.</p></fn><fn id="T0002-fn8"><label>&#x02016;</label><p>Only mentioned in SCCS conclusion and not in any cited study.</p></fn><fn id="T0002-fn9"><label>i</label><p>Adaptive compensatory.</p></fn></table-wrap-foot></table-wrap><p>Additionally, toxic effects not caused by the test substance are described using terms like &#x0201c;incidental&#x0201d; and &#x0201c;doubtful.&#x0201d; Expressions like &#x0201c;no adverse&#x0201d; and &#x0201c;adaptive compensatory&#x0201d; also require clarification to ensure that the intended meaning is clear. From a scientific language perspective, terms such as &#x0201c;increase,&#x0201d; &#x0201c;raise,&#x0201d; and &#x0201c;higher&#x0201d; should be regarded as synonymous and interpreted accordingly when querying TOXIN KG. Variations in enzyme names also pose challenges; for example, &#x0201c;alanine aminotransferase&#x0201d; has been referred to as &#x0201c;serum glutamate-pyruvate transaminase,&#x0201d; with abbreviations like SGPT, GPT, ALAT, and ALT used in different opinions. TOXIN KG addresses these variations to ensure comprehensive search results comparable to those obtained manually using the Excel file containing the &#x0201c;raw data&#x0201d; of the SCCS opinions. Out of the 53 cosmetics identified as affecting at least one parameter related to liver toxicity in a 90-day RDT animal study, we manually found that 18 impact ALT levels. <xref rid="F7" ref-type="fig">Figure&#x000a0;7</xref> displays the search results in TOXIN KG for ingredients that impact ALT liver enzyme levels, showing how keywords such as &#x0201c;increase,&#x0201d; &#x0201c;higher,&#x0201d; and &#x0201c;decrease&#x0201d; are searched separately. Additionally, terms like &#x0201c;change,&#x0201d; &#x0201c;differ,&#x0201d; and &#x0201c;alter&#x0201d; are included to ensure a comprehensive search for ingredients reporting disturbances in ALT levels in animals. By addressing enzyme naming complexities and clarifying synonymous terms, TOXIN KG successfully retrieved all 18 relevant cosmetic ingredients affecting ALT levels, demonstrating its capability to match the accuracy of manual analysis.</p><fig position="float" id="F7" fig-type="figure"><label>Figure&#x000a0;7.</label><caption><p>Displaying search results in TOXIN KG for ingredients that impact the ALT liver enzyme levels.</p></caption><graphic xlink:href="baae121f7" position="float"/></fig><p>Substantial enhancements can still be introduced to the search function by applying NLP and LLMs. Leveraging NLP can improve the tool&#x02019;s understanding of user queries across diverse domains. NLP techniques such as Named Entity Recognition, Entity Linking, and Semantic Role Labeling can dissect user queries and extract pertinent information from opinions, thereby elevating the search results. Named Entity Recognition helps identify chemical compound names and essential terms, Entity Linking connects them to relevant database records, and Semantic Role Labeling assigns roles to words and breaks down user queries to understand the relationship between different parts. LLMs have also demonstrated their use in extracting information from text, interpreting texts, and translating questions in natural language to SPARQL queries [<xref rid="R72" ref-type="bibr">72</xref>]. While there have been significant advancements in NLP and AI-driven automated text analysis within the field of toxicology, additional fine-tuning is required before these technologies can be widely integrated into NGRA tools like TOXIN KG [<xref rid="R73" ref-type="bibr">73&#x02013;76</xref>].</p></sec><sec id="s3-s4"><title>TOXIN KG links observations to toxicological mechanisms through ontologies</title><p>In TOXIN KG, the enriched TXPO serves as the foundational framework, integrating data from various sources into a machine-friendly format and facilitating the exploration of toxicological data, including molecular pathways, cellular responses, and adverse outcomes [<xref rid="R19" ref-type="bibr">19</xref>]. TXPO&#x02019;s explicit relationships simplify data navigation and enhance interoperability, fostering connections across toxicology. Recognizing the importance of identifying KG requirements through competency questions, TOXIN KG adheres to this practice [<xref rid="R77" ref-type="bibr">77</xref>]. The required information may originate from diverse sources, ideally through a semiautomatic extraction process. Linking entity descriptions to external representations enhances concept comprehension, even though errors in linking are considered noncritical [<xref rid="R78" ref-type="bibr">78</xref>]. TOXIN KG integrates information from external sources by establishing links to these sources while keeping integrations separate from internal data stored in dedicated entities known as &#x0201c;named graphs.&#x0201d; This strategic approach ensures traceability, enabling the identification of information origins [<xref rid="R38" ref-type="bibr">38</xref>].</p><p>
<xref rid="F8" ref-type="fig">Figure&#x000a0;8</xref> showcases insights obtained using semantic technologies and an enriched ontology. The information from a 90-day oral repeated-dose OECD 408 test for Basic Red 51, retrieved by TOXIN KG, is potentially linked to a liver-specific adverse outcome. The top section of the figure presents features retrieved from the SCCS opinion, including information about the test species and three key observations presented in dashed circles: increased ALP and GGT (from the clinical biochemistry end point) and hepatocellular necrosis (from histopathology). The bottom section of the figure includes entities from the TOXIN Enriched Knowledge Graph (TEKG), which integrates toxicological data from SCCS opinions with additional sources (enriched TXPO). These observations, &#x0201c;increased ALP,&#x0201d; &#x0201c;presence of GGT,&#x0201d; and &#x0201c;necrosis&#x0201d; are depicted in trapezoids and are linked to toxicological data through various relationships. Relationships are represented by arrows. Direct links are established in a &#x0201c;sameAs&#x0201d; relation between TOXIN KG and TEKG (solid lines), while dashed arrows indicate indirect links. Dashed lines symbolize indirect inheritance, and dotted lines denote indirect relations. Indirect inheritance allows flexible knowledge representation through intermediate classes, while indirect relations signify inferred connections not explicitly stated but deduced from the ontology structure [<xref rid="R37" ref-type="bibr">37</xref>]. The &#x0201c;sameAs&#x0201d; link and the &#x0201c;is affected by&#x0201d; link demonstrate linguistic-based rationale. &#x0201c;sameAs&#x0201d; indicates linguistic similarity, while &#x0201c;is affected by&#x0201d; links are inferred through reasoning, counting common effects between a disease and an opinion. These automated links offer insights into the likelihood that Basic Red 51 suggests liver cholestasis in the test subject. Ontologies and semantic technologies enable automation, while machine learning can also derive the &#x0201c;is affected by&#x0201d; relationship.</p><fig position="float" id="F8" fig-type="figure"><label>Figure&#x000a0;8.</label><caption><p>Relationships and features in TOXIN KG and TEKG for Basic Red 51, linking observations from OECD 408 tests to toxicological entities through direct and indirect relationships.</p></caption><graphic xlink:href="baae121f8" position="float"/></fig><p>
<xref rid="F9" ref-type="fig">Figure&#x000a0;9</xref>, powered by Ontodia, introduces competency questions tailored to TOXIN KG, demonstrating how TEKG uses linked data to meet specific data retrieval needs and answer these questions. In <xref rid="F9" ref-type="fig">Fig.&#x000a0;9</xref>, Zone a (solid line) illustrates the competency question: &#x0201c;Knowing some adverse effects observed in a subject, what diseases or toxic processes may affect this subject?&#x0201d; On the left, it depicts the relationships between toxic processes, adverse effects, and their interactions. Three key points are highlighted: &#x0201c;NAFLD&#x0201d; is categorized under &#x0201c;lipidosis,&#x0201d; indicating their connection. Two upward arrows represent adverse effects specific to NAFLD. Two hyperfunction symbols indicate adverse effects inherited by NAFLD from lipidosis, as NAFLD is a subtype of lipidosis. This illustrates the presence of these effects in NAFLD due to its classification. Additionally, the adverse effect &#x0201c;increasing blood ALP concentration&#x0201d; is linked to cholestasis using the &#x0201c;has context&#x0201d; predicate, while the &#x0201c;has part&#x0201d; predicate connects adverse effects to toxic processes, such as linking NAFLD to the hyperfunction of lipid biosynthesis. This approach enhances the organization and retrieval of information on specific adverse effects occurring within toxic events.</p><fig position="float" id="F9" fig-type="figure"><label>Figure&#x000a0;9.</label><caption><p>TEKG applications visualized through Ontodia, showcasing linked data to address competency questions on toxic processes, biological pathways, and compromised gene or protein functionality.</p></caption><graphic xlink:href="baae121f9" position="float"/></fig><p>TEKG helps determine biological processes or pathways influenced by a disease. In <xref rid="F9" ref-type="fig">Fig.&#x000a0;9</xref>, Zone b (dotted line) addresses the competency question: &#x0201c;What biological processes or pathways are impacted by a specific disease?&#x0201d; Here, NAFLD is linked to various pathways, including the &#x0201c;fatty acid biosynthetic process&#x0201d; and GO-CAM models, showing TEKG&#x02019;s ability to identify affected biological processes. Zone c (dashed line) focuses on the question: &#x0201c;Which gene or protein&#x02019;s functionality is hindered by a toxic process?&#x0201d; It depicts accessing gene products related to biological processes, such as acetyl-CoA carboxylase 1, involved in lipid metabolism. This gene represents a potential target for follow-up <italic toggle="yes">in vitro</italic> studies. [<xref rid="R79" ref-type="bibr">79&#x02013;81</xref>].</p><p>Direct and indirect links are displayed interactively within the TOXIN KG environment, categorizing compounds affecting the same pathways based on <italic toggle="yes">in vivo</italic> data. For instance, &#x0201c;increased ALP&#x0201d; is common among eight ingredients, such as Basic Red 51 and phenoxyethanol (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>). Ontodia allows the grouping of these ingredients for further investigation, advancing SARs for liver toxicity [<xref rid="R82" ref-type="bibr">82&#x02013;85</xref>]. The examples focusing on liver toxicity and related parameters can extend to other organs by broadening the search filters.</p></sec></sec><sec id="s4"><title>Related work</title><p>In toxicology, TOXIN KG has been instrumental in developing an NGRA case study to thoroughly evaluate the liver toxicity of the hair dye HC Yellow No. 13 (HCY13). Historical <italic toggle="yes">in vivo</italic> data within TOXIN KG flagged HCY13 for its hepatotoxic potential (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>), while the <italic toggle="yes">in silico</italic> tools, including the OECD QSAR Toolbox and HESS toxicological profiler, identified a structural alert associated with fat accumulation (steatosis). Subsequent targeted <italic toggle="yes">in vitro</italic> tests with human hepatic-like cells assessed lipid metabolism-related markers and triglyceride accumulation, and a physiologically based pharmacokinetic model estimated internal liver concentrations of HCY13. These combined results confirmed that 2.5% HCY13 would not trigger liver steatosis under the assumed use conditions. Such case studies advance animal-free toxicity assessments and contribute to developing NGRA methodology. A detailed manuscript elaborating on these findings and methods is currently being prepared.</p><p>For KG generation, we adopted R2RML to transform CSV files into RDF using SQL, leveraging built-in SQL functions for data manipulation. At the time of writing, the RDF Mapping Language (RML) community, which proposes a &#x0201c;superset&#x0201d; of R2RML to transform any data into RDF, has started consolidating their efforts [<xref rid="R86" ref-type="bibr">86</xref>]. Although RML is still evolving and not yet a standard, tools like RMLWrapper (<ext-link xlink:href="https://rml.io/tools/" ext-link-type="uri">https://rml.io/tools/</ext-link>) and Morph-KGC (<ext-link xlink:href="https://github.com/morph-kgc/morph-kgc" ext-link-type="uri">https://github.com/morph-kgc/morph-kgc</ext-link>) add complexity by requiring additional languages, such as Python. Given that R2RML meets our current needs, we chose to rely on this standard. Once RML is more stable, we may transition to an RML processor like BURP [<xref rid="R87" ref-type="bibr">87</xref>].</p></sec><sec id="s5"><title>Future directions</title><p>By integrating advanced AI-based tools and methodologies within TOXIN KG, we aim further to enhance data accuracy, completeness, and reliability, thereby supporting more robust and comprehensive toxicological assessments. At the start of the project in 2020, advanced AI tools like ChatGPT were yet to be available to replace manual text processes for data gathering, structuring, and input. As the field has rapidly evolved, several AI-based tools and methods are proposed for future implementation to enhance TOXIN KG&#x02019;s capabilities. These include developing a pipeline using NLP and LLMs to automate data gathering from the EU health page, improving data capture efficiency and consistency, and addressing the manual effort needed due to the lack of harmonized naming systems [<xref rid="R88" ref-type="bibr">88</xref>].</p><p>The TOXIN Report Analyzer (under development) employs ChatGPT-4 to extract text from SCCS opinions and convert them into easy-to-understand tables. This process relies on incorporating precise prompts (specific instructions given to the AI model), guided by domain experts and guideline profiling, to ensure data accuracy and completeness, aligning with OECD guidelines. While AI aids in streamlining the process, domain experts will continue to review and correct the AI-generated tables to ensure accuracy [<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R89" ref-type="bibr">89</xref>].</p><p>Automated consistency checks will also be implemented to improve data accuracy and completeness. AI tools will perform these checks at both the data extraction and input stages. Machine learning models will recognize patterns, validate data entries, and improve through expert corrections. Additionally, ontology-based tools will ensure semantic consistency by verifying that the data adhere to the structured format defined by the TXPO [<xref rid="R90" ref-type="bibr">90</xref>, <xref rid="R91" ref-type="bibr">91</xref>].</p><p>In addition, a continuous feedback loop will be implemented with regular usability studies involving domain experts to refine TOXIN KG. These studies will assess navigation, ease of use, data accuracy, and efficiency across all interfaces. Experts will perform specific tasks using the different interfaces, with metrics like completion times, error rates, and user satisfaction measured. Postinteraction surveys and questionnaires will collect quantitative and qualitative feedback. Regular user feedback sessions will include structured interviews to discuss experiences, while analytics and user behavior tracking will identify patterns and difficulties, allowing continuous improvements to interface-based user feedback [<xref rid="R92" ref-type="bibr">92</xref>, <xref rid="R93" ref-type="bibr">93</xref>].</p></sec><sec id="s6"><title>Conclusion</title><p>In conclusion, TOXIN KG is a multifaceted tool and gateway designed for ease of use. It offers access to existing cosmic historical animal safety data. It captures and annexes the wealth of knowledge embedded in SCCS opinions within a machine-processable graph format, obviating the need for intermediaries like gateways. This approach enables efficient <italic toggle="yes">in silico</italic> predictions and establishes a pivotal resource for exploring cosmetics-induced liver toxicity. Specifically, TOXIN KG helps identify and map biological pathways while elucidating the genes affected by toxic processes, laying the foundation for a deeper understanding of the intricacies involved. This knowledge is instrumental in guiding subsequent targeted <italic toggle="yes">in vitro</italic> studies utilizing human-based NAMs, thus contributing to generating novel mechanistic data.</p></sec></body><back><ack id="ack1"><title>Acknowledgement</title><p>The authors would like to thank Morvarid Haji Mirarab for providing Figs&#x000a0;3 and 9.</p></ack><sec sec-type="COI-statement" id="s7"><title>Conflict of interest</title><p>None declared.</p></sec><sec id="s8"><title>Funding</title><p>This work was financially supported by Onderzoeksraad Vrije Universiteit Brussel and Research Chair Mireille Aerens for the development of Alternatives to Animal Testing. The research of Audrey Sanctorum has been funded by an FWO Postdoc Fellowship (1276721N) of the Research Foundation Flanders.</p></sec><sec sec-type="data-availability" id="s9"><title>Data Availability</title><p>The data underlying this article are available in the article and in its online supplementary material.</p></sec><ref-list id="ref1"><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>SCCS/1647/22</collab>
</person-group>. <article-title>SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation 12th revision</article-title>, <year>2023</year>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Silva</surname> &#x000a0;<given-names>RJ</given-names></string-name>, <string-name><surname>Tamburic</surname> &#x000a0;<given-names>S</given-names></string-name></person-group>. <article-title>A state-of-the-art review on the alternatives to animal testing for the safety assessment of cosmetics</article-title>. <source><italic toggle="yes">Cosmetics</italic></source> &#x000a0;<year>2022</year>;<volume>9</volume>:<page-range>90</page-range>. doi: <pub-id pub-id-type="doi">10.3390/cosmetics9050090</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>OECD</collab>
</person-group>. <article-title>Overview of concepts and available guidance related to Integrated Approaches to Testing and Assessment (IATA)</article-title>. <source>Environment, Health and Safety, Environment Directorate</source>, OECD (329). 2020.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cronin</surname> &#x000a0;<given-names>MTD</given-names></string-name>, <string-name><surname>Bajot</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Enoch</surname> &#x000a0;<given-names>SJ</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The in chemico-in silico interface: challenges for integrating experimental and computational chemistry to identify toxicity</article-title>. <source><italic toggle="yes">Altern Lab Anim</italic></source> &#x000a0;<year>2009</year>;<volume>37</volume>:<fpage>513</fpage>&#x02013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1177/026119290903700508</pub-id><pub-id pub-id-type="pmid">20017580</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>NNLM</collab>
</person-group>. <article-title>Data Curation</article-title>. 2022. <ext-link xlink:href="https://www.nnlm.gov/guides/data-glossary/data-curation" ext-link-type="uri">https://www.nnlm.gov/guides/data-glossary/data-curation</ext-link> (24 October 2023, date last accessed).</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gustafson</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Debruyne</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>De Troyer</surname> &#x000a0;<given-names>O</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019</article-title>. <source><italic toggle="yes">Arch Toxicol</italic></source> &#x000a0;<year>2020</year>;<volume>94</volume>:<fpage>3723</fpage>&#x02013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00204-020-02868-2</pub-id><pub-id pub-id-type="pmid">32839844</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>SCCS/1322/10</collab>
</person-group>. <article-title>SCCS &#x02013; Opinion on HC Yellow no 13</article-title>. <year>2011</year>. <ext-link xlink:href="https://health.ec.europa.eu/scientific-committees/scientific-committee-consumer-safety-sccs/sccs-opinions_en" ext-link-type="uri">https://health.ec.europa.eu/scientific-committees/scientific-committee-consumer-safety-sccs/sccs-opinions_en</ext-link> (<comment>13 November 2024</comment>, date last accessed)</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>Microsoft Support</collab>
</person-group>. <article-title>Excel Specifications and Limits</article-title>. <ext-link xlink:href="https://support.microsoft.com/en-us/office/excel-specifications-and-limits-1672b34d-7043-467e-8e27-269d656771c3" ext-link-type="uri">https://support.microsoft.com/en-us/office/excel-specifications-and-limits-1672b34d-7043-467e-8e27-269d656771c3</ext-link> (<comment>11 October 2024</comment>, date last accessed)</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Das</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Cyganiak</surname> &#x000a0;<given-names>R</given-names></string-name>, and <string-name><surname>Sundara</surname> &#x000a0;<given-names>S</given-names></string-name></person-group>. <article-title>R2RML: RDB to RDF Mapping Language</article-title>. <year>2012</year>. <ext-link xlink:href="https://www.w3.org/TR/r2rml/" ext-link-type="uri">https://www.w3.org/TR/r2rml/</ext-link> (<comment>11 October 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author">
<string-name>
<surname>Debruyne</surname> &#x000a0;<given-names>C</given-names></string-name>, and <string-name><surname>O&#x02019;Sullivan</surname> &#x000a0;<given-names>D.</given-names></string-name></person-group> &#x000a0;<article-title>R2RML-F: towards shar-ing and executing domain logic in R2RML mappings</article-title>. In: <italic toggle="yes">LDOW@WWW</italic> &#x000a0;<volume>1593</volume>. <conf-loc>Montreal, Canada</conf-loc>, <conf-date>12 April 2016</conf-date>. <fpage>CEUR</fpage>-<lpage>WS.org</lpage>, <year>2016</year>. <ext-link xlink:href="https://ceur-ws.org/Vol-1593/article-13.pdf" ext-link-type="uri">https://ceur-ws.org/Vol-1593/article-13.pdf</ext-link> (<comment>11 October 2024, date last accessed)</comment>.</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sanctorum</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Riggio</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Maushagen</surname> &#x000a0;<given-names>J</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>End-user engineering of ontology-based knowledge bases</article-title>. <source><italic toggle="yes">Behaviour Inf Technol</italic></source> &#x000a0;<year>2022</year>;<volume>41</volume>:<fpage>1811</fpage>&#x02013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1080/0144929X.2022.2092032</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>OECD</collab>
</person-group>. <article-title>Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents</article-title>. <year>2018</year> (<source>OECD Guidelines for the Testing of Chemicals, Section&#x000a0;4</source>). <ext-link xlink:href="https://www.oecd-ilibrary.org/environment/test-no-408-repeated-dose-90-day-oral-toxicity-study-in-rodents_9789264070707-en" ext-link-type="uri">https://www.oecd-ilibrary.org/environment/test-no-408-repeated-dose-90-day-oral-toxicity-study-in-rodents_9789264070707-en</ext-link> (<comment>28 September 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Shen</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>X</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>DataType-aware knowledge graph representation learning in hyperbolic space</article-title>. In:<italic toggle="yes">International Conference on Information and Knowledge Management, Proceedings Online</italic>, <conf-date>1&#x02013;5 November 2021</conf-date>. pp. <fpage>1630</fpage>&#x02013;<lpage>39</lpage>. Gold Coast, Queensland, Australia: ACM Digital Library, 2021.</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Sanctorum</surname> &#x000a0;<given-names>A</given-names></string-name>
<string-name>
<surname>Riggio</surname> &#x000a0;<given-names>J</given-names></string-name>
<string-name>
<surname>Sepehri</surname> &#x000a0;<given-names>S</given-names></string-name>
</person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<part-title>A jigsaw-based end-user tool for the development of ontology-based knowledge bases</part-title>. In: <person-group person-group-type="editor"><string-name><surname>Fogli</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Tetteroo</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Barricelli</surname> &#x000a0;<given-names>BR</given-names></string-name>, <string-name><surname>Borsci</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Markopoulos</surname> &#x000a0;<given-names>P</given-names></string-name> and <string-name><surname>Papadopoulos</surname> &#x000a0;<given-names>GA</given-names></string-name></person-group> (eds), <source><italic toggle="yes">End-User Development IS-EUD Gewerbestrasse 11, Cham, Ch 6330</italic></source>. <series>Lecture Notes in Computer Science</series>. Vol. <volume>12724</volume>.<publisher-loc>Switzerland</publisher-loc>: <publisher-name>Springer, Cham</publisher-name>. <year>2021</year>, pp. <fpage>169</fpage>&#x02013;<lpage>84</lpage>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Collier</surname> &#x000a0;<given-names>ZA</given-names></string-name>, <string-name><surname>Gruss</surname> &#x000a0;<given-names>RJ</given-names></string-name>, and <string-name><surname>Abrahams</surname> &#x000a0;<given-names>AS</given-names></string-name></person-group>. <article-title>How Good Are Large Language Models at Product Risk Assessment? Risk Analysis</article-title>. <ext-link xlink:href="https://onlinelibrary.wiley.com/doi/full/10.1111/risa.14351" ext-link-type="uri">https://onlinelibrary.wiley.com/doi/full/10.1111/risa.14351</ext-link> (<comment>12 November 2024</comment>, date last accessed)</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fu</surname> &#x000a0;<given-names>X</given-names></string-name>, <string-name><surname>Wojak</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Neagu</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Data governance in predictive toxicology: a review</article-title>. <source><italic toggle="yes">J Cheminform</italic></source> &#x000a0;<year>2011</year>;<volume>3</volume>:<page-range>24</page-range>. doi: <pub-id pub-id-type="doi">10.1186/1758-2946-3-24</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Kumar</surname> &#x000a0;<given-names>BS</given-names></string-name>, and <string-name><surname>Kumar</surname> &#x000a0;<given-names>BS</given-names></string-name></person-group>. <article-title>Introductory Chapter: Data Integrity and Data Governance</article-title>. <source>Data Integrity and Data Governance</source>. <ext-link xlink:href="https://www.intechopen.com/chapters/86485" ext-link-type="uri">https://www.intechopen.com/chapters/86485</ext-link> (<comment>17 November 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nikam</surname> &#x000a0;<given-names>NR</given-names></string-name>, <string-name><surname>Patil</surname> &#x000a0;<given-names>PR</given-names></string-name>, <string-name><surname>Vakhariya</surname> &#x000a0;<given-names>R</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Data integrity: an overview</article-title>. <source><italic toggle="yes">Int J Recent Sci Res</italic></source> &#x000a0;<year>2020</year>;<volume>11</volume>:<fpage>38762</fpage>&#x02013;<lpage>67</lpage>.</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamagata</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Yamada</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Horii</surname> &#x000a0;<given-names>I</given-names></string-name></person-group>. <article-title>Current status and future perspective of computational toxicology in drug safety assessment under ontological intellection</article-title>. <source><italic toggle="yes">J Toxicol Sci</italic></source> &#x000a0;<year>2019</year>;<volume>44</volume>:<fpage>721</fpage>&#x02013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.2131/jts.44.721</pub-id><pub-id pub-id-type="pmid">31708530</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Staal</surname> &#x000a0;<given-names>YCM</given-names></string-name>, <string-name><surname>Pennings</surname> &#x000a0;<given-names>JLA</given-names></string-name>, <string-name><surname>Hessel</surname> &#x000a0;<given-names>EVS</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Advanced toxicological risk assessment by implementation of ontologies operationalized in computational models</article-title>. <source><italic toggle="yes">Appl In Vitro Toxicol</italic></source> &#x000a0;<year>2017</year>;<volume>3</volume>:<fpage>325</fpage>&#x02013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1089/aivt.2017.0019</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Boyles</surname> &#x000a0;<given-names>RR</given-names></string-name>, <string-name><surname>Thessen</surname> &#x000a0;<given-names>AE</given-names></string-name>, <string-name><surname>Waldrop</surname> &#x000a0;<given-names>A</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Ontology-based data integration for advancing toxicological knowledge</article-title>. <source><italic toggle="yes">Curr Opin Toxicol</italic></source> &#x000a0;<year>2019</year>;<volume>16</volume>:<fpage>67</fpage>&#x02013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cotox.2019.05.005</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hardy</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Apic</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Carthew</surname> &#x000a0;<given-names>P</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Toxicology ontology perspectives</article-title>. <source><italic toggle="yes">Altex</italic></source> &#x000a0;<year>2012</year>;<volume>29</volume>:<fpage>139</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">22562487</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Bretones Cassoli</surname> &#x000a0;<given-names>B.</given-names></string-name>
</person-group> &#x000a0;<article-title>Knowledge Graphs for Data And Knowledge Management in Cyber-Physical Production Systems</article-title>. <year>2022</year> &#x000a0;<ext-link xlink:href="https://www.repo.uni-hannover.de/handle/123456789/12278" ext-link-type="uri">https://www.repo.uni-hannover.de/handle/123456789/12278</ext-link> (<comment>17 November 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mungall</surname> &#x000a0;<given-names>CJ</given-names></string-name>, <string-name><surname>Torniai</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Gkoutos</surname> &#x000a0;<given-names>GV</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Uberon, an integrative multi-species anatomy ontology</article-title>. <source><italic toggle="yes">Genome Biol</italic></source> &#x000a0;<year>2012</year>;<volume>13</volume>:<fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hastings</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>De Matos</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>Dekker</surname> &#x000a0;<given-names>A</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2012</year>;<volume>41</volume>:<page-range>D456</page-range>. doi: <pub-id pub-id-type="doi">10.1093/nar/gks1146</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ashburner</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Ball</surname> &#x000a0;<given-names>CA</given-names></string-name>, <string-name><surname>Blake</surname> &#x000a0;<given-names>JA</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Gene ontology: tool for the unification of biology</article-title>. <source><italic toggle="yes">Nature Genet</italic></source> &#x000a0;<year>2000</year>;<volume>25</volume>:<fpage>25</fpage>&#x02013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Consortium</surname> &#x000a0;<given-names>TGO</given-names></string-name>, <string-name><surname>Aleksander</surname> &#x000a0;<given-names>SA</given-names></string-name>, <string-name><surname>Balhoff</surname> &#x000a0;<given-names>J</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The gene ontology knowledgebase in 2023</article-title>. <source><italic toggle="yes">Genetics</italic></source> &#x000a0;<year>2023</year>;<volume>224</volume>:<page-range>iyad031</page-range> doi: <pub-id pub-id-type="doi">10.1093/genetics/iyad031</pub-id>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Yamamoto</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Sakai</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Nakamura</surname> &#x000a0;<given-names>H</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Inoh: Ontology-Based Highly Structured Database of Signal Transduction Pathways</article-title>. <source>Database (Oxford)</source>. <year>2011</year>. <ext-link xlink:href="http:///pmc/articles/PMC3225078/" ext-link-type="uri">/pmc/articles/PMC3225078/</ext-link> (<comment>29 September 2024</comment>, date last accessed)</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>He</surname> &#x000a0;<given-names>Yongqun</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Yue</given-names></string-name>, and <string-name><surname>Zhao</surname> &#x000a0;<given-names>Bin</given-names></string-name></person-group>. <article-title>OGG: A Biological Ontology for Representing Genes and Genomes in Specific Organ-isms International Conference on Biomedical Ontology (ICBO)</article-title>. In: <italic toggle="yes">CEUR Workshop Proceedings 1327</italic>, <conf-date>8&#x02013;9 October 2014</conf-date>, <fpage>13</fpage>&#x02013;<lpage>20</lpage>. Houston, Texas, USA, 2014.</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schriml</surname> &#x000a0;<given-names>LM</given-names></string-name>, <string-name><surname>Munro</surname> &#x000a0;<given-names>JB</given-names></string-name>, <string-name><surname>Schor</surname> &#x000a0;<given-names>M</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The human disease ontology 2022 update</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2022</year>;<volume>50</volume>:<page-range>D1255</page-range>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab1063</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamagata</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Yamada</surname> &#x000a0;<given-names>H</given-names></string-name></person-group>. <article-title>Ontological approach to the knowledge systematization of a toxic process and toxic course representation framework for early drug risk management</article-title>. <source><italic toggle="yes">Sci Rep</italic></source> &#x000a0;<year>2020</year>;<volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-71370-7</pub-id><pub-id pub-id-type="pmid">31913322</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bateman</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>MJ</given-names></string-name>, <string-name><surname>Orchard</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>UniProt: the universal protein knowledgebase in 2023</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2023</year>;<volume>51</volume>:<fpage>D523</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">36408920</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kanehisa</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Furumichi</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Sato</surname> &#x000a0;<given-names>Y</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>KEGG for taxonomy-based analysis of pathways and genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2023</year>;<volume>51</volume>:<fpage>D587</fpage>&#x02013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac963</pub-id><pub-id pub-id-type="pmid">36300620</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kanehisa</surname> &#x000a0;<given-names>M</given-names></string-name>
</person-group>. <article-title>Toward understanding the origin and evolution of cellular organisms</article-title>. <source><italic toggle="yes">Protein Sci</italic></source> &#x000a0;<year>2019</year>;<volume>28</volume>:<fpage>1947</fpage>&#x02013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1002/pro.3715</pub-id><pub-id pub-id-type="pmid">31441146</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kanehisa</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Goto</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Kawashima</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The KEGG databases at GenomeNet</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2002</year>;<volume>30</volume>:<fpage>42</fpage>&#x02013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/30.1.42</pub-id><pub-id pub-id-type="pmid">11752249</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kanehisa</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Goto</surname> &#x000a0;<given-names>S</given-names></string-name></person-group>. <article-title>Kyoto encyclopedia of genes and genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2000</year>;<volume>28</volume>:<fpage>27</fpage>&#x02013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gillespie</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Jassal</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Stephan</surname> &#x000a0;<given-names>R</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The reactome pathway knowledgebase 2022</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2022</year>;<volume>50</volume>:<fpage>D687</fpage>&#x02013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab1028</pub-id><pub-id pub-id-type="pmid">34788843</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Debruyne</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Munnelly</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Kilgallon</surname> &#x000a0;<given-names>L</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Creating a knowledge graph for Ireland&#x02019;s lost history: knowledge engineering and curation in the beyond 2022 Project</article-title>. <source><italic toggle="yes">J Comput Cult Herit</italic></source> &#x000a0;<year>2022</year>;<volume>15</volume>:<page-range>1 - 25/25</page-range>. doi: <pub-id pub-id-type="doi">10.1145/3474829</pub-id>.</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Sanctorum</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Maushagen</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Sepehri</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Knowledge Management in the Context of Toxicity Testing. From Theory of Knowledge Management to Practice</article-title>. 2023. <ext-link xlink:href="https://www.intechopen.com/chapters/1147484" ext-link-type="uri">https://www.intechopen.com/chapters/1147484</ext-link> (<comment>3 September 2024, date last accessed</comment>)</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Weininger</surname> &#x000a0;<given-names>D</given-names></string-name>
</person-group>. <article-title>SMILES, a chemical language and information system: 1: introduction to methodology and encoding rules</article-title>. <source><italic toggle="yes">J Chem Inf Comput Sci</italic></source> &#x000a0;<year>1988</year>;<volume>28</volume>:<fpage>31</fpage>&#x02013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ci00057a005</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Born</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Markert</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Janakarajan</surname> &#x000a0;<given-names>N</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Chemical representation learning for toxicity prediction</article-title>. <source><italic toggle="yes">Digit Discov</italic></source> &#x000a0;<year>2023</year>;<volume>2</volume>:<fpage>674</fpage>&#x02013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1039/D2DD00099G</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>O&#x02019;Boyle</surname> &#x000a0;<given-names>NM</given-names></string-name>
</person-group>. <article-title>Towards a Universal SMILES representation &#x02013; a standard method to generate canonical SMILES based on the InChI</article-title>. <source><italic toggle="yes">J Cheminform</italic></source> &#x000a0;<year>2012</year>;<volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">22236646</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Klimisch</surname> &#x000a0;<given-names>H-J</given-names></string-name>, <string-name><surname>Andreae</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Tillmann</surname> &#x000a0;<given-names>U</given-names></string-name></person-group>. <article-title>A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data</article-title>. <source><italic toggle="yes">Regul Toxicol Pharmacol</italic></source> &#x000a0;<year>1997</year>;<volume>25</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1006/rtph.1996.1076</pub-id><pub-id pub-id-type="pmid">9056496</pub-id>
</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schneider</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Schwarz</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Burkholder</surname> &#x000a0;<given-names>I</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>&#x0201c;ToxRTool&#x0201d;, a new tool to assess the reliability of toxicological data</article-title>. <source><italic toggle="yes">Toxicol Lett</italic></source> &#x000a0;<year>2009</year>;<volume>189</volume>:<fpage>138</fpage>&#x02013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.toxlet.2009.05.013</pub-id><pub-id pub-id-type="pmid">19477248</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Segal</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Makris</surname> &#x000a0;<given-names>SL</given-names></string-name>, <string-name><surname>Kraft</surname> &#x000a0;<given-names>AD</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Evaluation of the ToxRTool&#x02019;s ability to rate the reliability of toxicological data for human health hazard assessments</article-title>. <source><italic toggle="yes">Regul Toxicol Pharmacol</italic></source> &#x000a0;<year>2015</year>;<volume>72</volume>:<fpage>94</fpage>&#x02013;<lpage>101</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yrtph.2015.03.005</pub-id><pub-id pub-id-type="pmid">25777839</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Johnson</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Anger</surname> &#x000a0;<given-names>LT</given-names></string-name>, <string-name><surname>Benigni</surname> &#x000a0;<given-names>R</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Evaluating confidence in toxicity assessments based on experimental data and in silico predictions</article-title>. <source><italic toggle="yes">Comput Toxicol</italic></source> &#x000a0;<year>2022</year>;<volume>21</volume>:<page-range>100204</page-range>.</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dimitrov</surname> &#x000a0;<given-names>SD</given-names></string-name>, <string-name><surname>Diderich</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Sobanski</surname> &#x000a0;<given-names>T</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>QSAR toolbox &#x02013; workflow and major functionalities</article-title>. <source><italic toggle="yes">SAR QSAR Environ Res</italic></source> &#x000a0;<year>2016</year>;<volume>27</volume>:<fpage>203</fpage>&#x02013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1062936X.2015.1136680</pub-id><pub-id pub-id-type="pmid">26892800</pub-id>
</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Toropov</surname> &#x000a0;<given-names>AA</given-names></string-name>, <string-name><surname>Toropova</surname> &#x000a0;<given-names>AP</given-names></string-name></person-group>. <article-title>QSPR/QSAR: state-of-art, weirdness, the future</article-title>. <source><italic toggle="yes">Molecules</italic></source> &#x000a0;<year>2020</year>;<volume>25</volume>:<page-range>1292</page-range>. doi: <pub-id pub-id-type="doi">10.3390/molecules25061292</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>OECD, ECHA, Laboratory of Mathematical Chemistry</collab>
</person-group>. <article-title><italic toggle="yes">Profilers</italic> &#x02b23; <italic toggle="yes">QSAR Toolbox</italic></article-title>. <year>2024</year>. <ext-link xlink:href="https://qsartoolbox.org/resources/profilers/" ext-link-type="uri">https://qsartoolbox.org/resources/profilers/</ext-link> (<comment>6 September 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>Safety Assessment Division CMCNI of T and E</collab>
</person-group>. <article-title>Hazard Evaluation Support System Integrated Platform (HESS)</article-title>. <year>2023</year>. <ext-link xlink:href="https://www.nite.go.jp/en/chem/qsar/hess-e.html" ext-link-type="uri">https://www.nite.go.jp/en/chem/qsar/hess-e.html</ext-link> (<comment>6 September 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>More</surname> &#x000a0;<given-names>SJ</given-names></string-name>, <string-name><surname>Bampidis</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Benford</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Guidance on the use of the threshold of toxicological concern approach in food safety assessment</article-title>. <source><italic toggle="yes">EFSA J</italic></source> &#x000a0;<year>2019</year>;<volume>17</volume>:<page-range>e05708</page-range>.</mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cramer</surname> &#x000a0;<given-names>GM</given-names></string-name>, <string-name><surname>Ford</surname> &#x000a0;<given-names>RA</given-names></string-name>, <string-name><surname>Hall</surname> &#x000a0;<given-names>RL</given-names></string-name></person-group>. <article-title>Estimation of toxic hazard&#x02014;a decision tree approach</article-title>. <source><italic toggle="yes">Food Cosmet Toxicol</italic></source> &#x000a0;<year>1976</year>;<volume>16</volume>:<fpage>255</fpage>&#x02013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0015-6264(76)80522-6</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Munro</surname> &#x000a0;<given-names>IC</given-names></string-name>, <string-name><surname>Ford</surname> &#x000a0;<given-names>RA</given-names></string-name>, <string-name><surname>Kennepohl</surname> &#x000a0;<given-names>E</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Thresholds of toxicological concern based on structure-activity relationships</article-title>. <source><italic toggle="yes">Drug Metab Rev</italic></source> &#x000a0;<year>1996</year>;<volume>28</volume>:<fpage>209</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.3109/03602539608994000</pub-id><pub-id pub-id-type="pmid">8744597</pub-id>
</mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>OECD, ECHA, Laboratory of Mathematical Chemistry</collab>
</person-group>. <article-title>Application manual of OECD QSAR Toolbox v.4 (F1 help)</article-title>. <year>2017</year>.</mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Aljallal</surname> &#x000a0;<given-names>MA</given-names></string-name>, <string-name><surname>Price</surname> &#x000a0;<given-names>NR</given-names></string-name>, <string-name><surname>Chaudhry</surname> &#x000a0;<given-names>Q</given-names></string-name></person-group>. <article-title>Assessment of performance of the profilers provided in the OECD QSAR toolbox for category formation of chemicals [Internet], nature portfolio</article-title>. <source><italic toggle="yes">Sci Rep</italic></source> &#x000a0;<year>2024</year>;<volume>14</volume>:<page-range>18330</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-69157-1</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sakuratani</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>HQ</given-names></string-name>, <string-name><surname>Nishikawa</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Hazard Evaluation Support System (HESS) for predicting repeated dose toxicity using toxicological categories</article-title>. <source><italic toggle="yes">SAR QSAR Environ Res</italic></source> &#x000a0;<year>2013</year>;<volume>24</volume>:<fpage>351</fpage>&#x02013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1062936X.2013.773375</pub-id><pub-id pub-id-type="pmid">23548036</pub-id>
</mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vinken</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Pauwels</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Ates</surname> &#x000a0;<given-names>G</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients</article-title>. <source><italic toggle="yes">Arch Toxicol</italic></source> &#x000a0;<year>2012</year>;<volume>86</volume>:<fpage>405</fpage>&#x02013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00204-011-0769-z</pub-id><pub-id pub-id-type="pmid">22038139</pub-id>
</mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pognan</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Beilmann</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Boonen</surname> &#x000a0;<given-names>HCM</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The evolving role of investigative toxicology in the pharmaceutical industry</article-title>. <source><italic toggle="yes">Nat Rev Drug Discov</italic></source> &#x000a0;<year>2023</year>;<volume>22</volume>:<fpage>317</fpage>&#x02013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41573-022-00633-x</pub-id><pub-id pub-id-type="pmid">36781957</pub-id>
</mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Van Norman</surname> &#x000a0;<given-names>GA</given-names></string-name>
</person-group>. <article-title>Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?</article-title> &#x000a0;<source><italic toggle="yes">JACC Basic Transl Sci</italic></source> &#x000a0;<year>2019</year>;<volume>4</volume>:<page-range>845</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jacbts.2019.10.008</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Akhtar</surname> &#x000a0;<given-names>A</given-names></string-name>
</person-group>. <article-title>The flaws and human harms of animal experimentation</article-title>. <source><italic toggle="yes">Cam Q Healthc Ethics</italic></source> &#x000a0;<year>2015</year>;<volume>24</volume>:<page-range>407</page-range>. doi: <pub-id pub-id-type="doi">10.1017/S0963180115000079</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tim&#x000f3;n-Reina</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Rinc&#x000f3;n</surname> &#x000a0;<given-names>M</given-names></string-name>, and <string-name><surname>Mart&#x000ed;nez-Tom&#x000e1;s</surname> &#x000a0;<given-names>R</given-names></string-name></person-group>. <article-title>An overview of graph databases and their applications in the biomedical domain</article-title>. <source><italic toggle="yes">Database</italic></source> &#x000a0;<volume>2021</volume>;<year>2021</year>:<page-range>26</page-range>.</mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Mouromtsev</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Pavlov</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Emelyanov</surname> &#x000a0;<given-names>Y</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The simple web-based tool for visualization and sharing of semantic data and ontologies</article-title>. <source>International Workshop on the Semantic Web</source>.</mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Komninos</surname> &#x000a0;<given-names>A</given-names></string-name>
</person-group>. <article-title>Interaction Design Foundation. An Introduction to Usability | IxDF</article-title>. <year>2020</year>. <ext-link xlink:href="https://www.interaction-design.org/literature/article/an-introduction-to-usability" ext-link-type="uri">https://www.interaction-design.org/literature/article/an-introduction-to-usability</ext-link> (<comment>21 September 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author">
<string-name>
<surname>Quesenbery</surname> &#x000a0;<given-names>W</given-names></string-name>
</person-group>. <article-title>What does usability mean: looking beyond &#x02018;Ease of Use&#x02019; &#x02013; Whitney interactive design</article-title>. In: <italic toggle="yes">Proceedings of the 48th Annual Conference, Society for Technical Communication</italic> &#x000a0;<conf-loc>Chicago</conf-loc> &#x000a0;<conf-date>13-16 May 2001</conf-date>, <year>2001</year>.</mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Boyce</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Favela</surname> &#x000a0;<given-names>KA</given-names></string-name>, <string-name><surname>Bonzo</surname> &#x000a0;<given-names>JA</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Identifying xenobiotic metabolites with in silico prediction tools and LCMS suspect screening analysis</article-title>. <source><italic toggle="yes">Front Toxicol</italic></source> &#x000a0;<year>2023</year>;<volume>5</volume>:<page-range>1051483</page-range>. doi: <pub-id pub-id-type="doi">10.3389/ftox.2023.1051483</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Boyce</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Meyer</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Grulke</surname> &#x000a0;<given-names>C</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Comparing the performance and coverage of selected in silico (liver) metabolism tools relative to reported studies in the literature to inform analogue selection in read-across: a case study</article-title>. <source><italic toggle="yes">Comput Toxicol</italic></source> &#x000a0;<year>2022</year>;<volume>21</volume>:<page-range>100208</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.comtox.2021.100208</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Euzenat</surname> &#x000a0;<given-names>J</given-names></string-name>, and <string-name><surname>Shvaiko</surname> &#x000a0;<given-names>P</given-names></string-name></person-group>. <part-title>Matching strategies</part-title>. In: <source><italic toggle="yes">Ontology Matching</italic></source>. <publisher-name>Berlin, Heidelberg: Springer</publisher-name>, <fpage>117</fpage>&#x02013;<lpage>150</lpage>.</mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Probst</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Reymond</surname> &#x000a0;<given-names>JL</given-names></string-name></person-group>. <article-title>SmilesDrawer: parsing and drawing SMILES-encoded molecular structures using client-side JavaScript</article-title>. <source><italic toggle="yes">J Chem Inf Model</italic></source> &#x000a0;<year>2018</year>;<volume>58</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00425</pub-id><pub-id pub-id-type="pmid">29257869</pub-id>
</mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname> &#x000a0;<given-names>TS</given-names></string-name>, <string-name><surname>Coley</surname> &#x000a0;<given-names>CW</given-names></string-name>, <string-name><surname>Mochigase</surname> &#x000a0;<given-names>H</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>BigSMILES: a structurally-based line notation for describing macromolecules</article-title>. <source><italic toggle="yes">ACS Cent Sci</italic></source> &#x000a0;<year>2019</year>;<volume>5</volume>:<fpage>1523</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acscentsci.9b00476</pub-id><pub-id pub-id-type="pmid">31572779</pub-id>
</mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname> &#x000a0;<given-names>TS</given-names></string-name>, <string-name><surname>Rebello</surname> &#x000a0;<given-names>NJ</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>GH</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Canonicalizing BigSMILES for polymers with defined backbones</article-title>. <source><italic toggle="yes">ACS Polymers Au</italic></source> &#x000a0;<year>2022</year>;<volume>2</volume>:<fpage>486</fpage>&#x02013;<lpage>500</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acspolymersau.2c00009</pub-id><pub-id pub-id-type="pmid">36561286</pub-id>
</mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ryan</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Grant</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Carrag&#x000e1;in</surname> &#x000a0;<given-names>E</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Linked data authority records for Irish place names</article-title>. <source><italic toggle="yes">Int J Digit Libr</italic></source> &#x000a0;<year>2015</year>;<volume>15</volume>:<fpage>73</fpage>&#x02013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00799-014-0129-8</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Yang</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Teng</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Dong</surname> &#x000a0;<given-names>X</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>LLM-based SPARQL generation with selected schema from large scale knowledge base: 304&#x02013;16</article-title>.</mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Romano</surname> &#x000a0;<given-names>JD</given-names></string-name>, <string-name><surname>Hao</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Moore</surname> &#x000a0;<given-names>JH</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Automating predictive toxicology using ComptoxAI</article-title>. <source><italic toggle="yes">Chem Res Toxicol</italic></source> &#x000a0;<year>2022</year>;<volume>35</volume>:<fpage>1370</fpage>&#x02013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.chemrestox.2c00074</pub-id><pub-id pub-id-type="pmid">35819939</pub-id>
</mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Walker</surname> &#x000a0;<given-names>VR</given-names></string-name>, <string-name><surname>Schmitt</surname> &#x000a0;<given-names>CP</given-names></string-name>, <string-name><surname>Wolfe</surname> &#x000a0;<given-names>MS</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Evaluation of a semi-automated data extraction tool for public health literature-based reviews: Dextr</article-title>. <source><italic toggle="yes">Environ Int</italic></source> &#x000a0;<year>2022</year>;<volume>159</volume>:<page-range>107025</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.envint.2021.107025</pub-id></mixed-citation></ref><ref id="R75"><label>75.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X</given-names></string-name>, <string-name><surname>Cao</surname> &#x000a0;<given-names>X</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Artificial intelligence: a powerful paradigm for scientific research</article-title>. <source><italic toggle="yes">Innovation</italic></source> &#x000a0;<year>2021</year>;<volume>2</volume>:<page-range>100179</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.xinn.2021.100179</pub-id></mixed-citation></ref><ref id="R76"><label>76.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Basile</surname> &#x000a0;<given-names>AO</given-names></string-name>, <string-name><surname>Yahi</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Tatonetti</surname> &#x000a0;<given-names>NP</given-names></string-name></person-group>. <article-title>Artificial intelligence for drug toxicity and safety</article-title>. <source><italic toggle="yes">Trends Pharmacol Sci</italic></source> &#x000a0;<year>2019</year>;<volume>40</volume>:<page-range>624</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.tips.2019.07.005</pub-id></mixed-citation></ref><ref id="R77"><label>77.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Gr&#x000fc;ninger</surname> &#x000a0;<given-names>M</given-names></string-name>
</person-group>, and <string-name><surname>Fox</surname> &#x000a0;<given-names>MS</given-names></string-name>. <part-title>The role of competency questions in enterprise engineering</part-title>. In: <string-name><surname>Asbj&#x000f8;rn</surname> &#x000a0;<given-names>Rolstad&#x000e5;s</given-names></string-name> (ed.), <source><italic toggle="yes">Benchmarking &#x02014; Theory and Practice</italic></source>. <series><italic toggle="yes">IFIP Advances in Information and Communication Technology ((IFIPAICT))</italic></series>. <publisher-name>Boston, MA</publisher-name>: Springer, <year>1995</year>, <fpage>22</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-0-387-34847-6_3</pub-id></mixed-citation></ref><ref id="R78"><label>78.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Vrande&#x0010d;i&#x000b4;vrande&#x0010d;i&#x000b4;c</surname> &#x000a0;<given-names>D.</given-names></string-name>
</person-group> &#x000a0;<part-title>Ontology evaluation</part-title>. In: <person-group person-group-type="editor"><string-name><surname>Staab</surname> &#x000a0;<given-names>Steffen</given-names></string-name>, <string-name><surname>Studer</surname> &#x000a0;<given-names>Rudi</given-names></string-name></person-group> (eds), <source><italic toggle="yes">Handbook on Ontologies</italic></source> &#x000a0;<series><italic toggle="yes">International Handbooks on Information Systems</italic></series>. <publisher-name>Springer</publisher-name>, 2009, 293&#x02013;313.</mixed-citation></ref><ref id="R79"><label>79.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tamura</surname> &#x000a0;<given-names>YO</given-names></string-name>, <string-name><surname>Sugama</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Iwasaki</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Selective acetyl-CoA carboxylase 1 inhibitor improves hepatic steatosis and hepatic fibrosis in a pre-clinical NASH model</article-title>. <source><italic toggle="yes">J Pharmacol Exp Ther</italic></source> &#x000a0;<year>2021</year>;<volume>379</volume>:<fpage>280</fpage>&#x02013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1124/jpet.121.000786</pub-id><pub-id pub-id-type="pmid">34535562</pub-id>
</mixed-citation></ref><ref id="R80"><label>80.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gnoni</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Di Chiara Stanca</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Giannotti</surname> &#x000a0;<given-names>L</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Quercetin reduces lipid accumulation in a cell model of NAFLD by inhibiting de novo fatty acid synthesis through the acetyl&#x02010;CoA carboxylase 1/AMPK/PP2A axis</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source> &#x000a0;<year>2022</year>;<volume>23</volume>:<page-range>1044</page-range>. doi: <pub-id pub-id-type="doi">10.3390/ijms23031044</pub-id></mixed-citation></ref><ref id="R81"><label>81.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Prins</surname> &#x000a0;<given-names>GH</given-names></string-name>, <string-name><surname>Luangmonkong</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Oosterhuis</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices</article-title>. <source><italic toggle="yes">Nutrients</italic></source> &#x000a0;<year>2019</year>;<volume>11</volume>:<page-range>507</page-range>. doi: <pub-id pub-id-type="doi">10.3390/nu11030507</pub-id></mixed-citation></ref><ref id="R82"><label>82.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wohlleben</surname> &#x000a0;<given-names>W</given-names></string-name>, <string-name><surname>Mehling</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Landsiedel</surname> &#x000a0;<given-names>R</given-names></string-name></person-group>. <article-title>Lessons learned from the grouping of chemicals to assess risks to human health</article-title>. <source><italic toggle="yes">Angew Chem Int Ed</italic></source> &#x000a0;<year>2023</year>;<volume>62</volume>:<page-range>e202210651</page-range>. doi: <pub-id pub-id-type="doi">10.1002/anie.202210651</pub-id></mixed-citation></ref><ref id="R83"><label>83.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Knudsen</surname> &#x000a0;<given-names>TB</given-names></string-name>
</person-group>. <article-title>Ontologies as the Basis for in Silico Reconstruction of Tissue Dynamics</article-title>. <year>2023</year>. <ext-link xlink:href="https://epa.figshare.com/articles/presentation/Ontologies_as_the_basis_for_in_silico_reconstruction_of_tissue_dynamics/24201369?file=42472152" ext-link-type="uri">https://epa.figshare.com/articles/presentation/Ontologies_as_the_basis_for_in_silico_reconstruction_of_tissue_dynamics/24201369?file=42472152</ext-link> (<comment>23 September 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R84"><label>84.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pawar</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Madden</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>Ebbrell</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>In silico toxicology data resources to support read-across and (Q)SAR</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source> &#x000a0;<year>2019</year>;<volume>10</volume>:<page-range>449547</page-range>.</mixed-citation></ref><ref id="R85"><label>85.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cronin</surname> &#x000a0;<given-names>MTD</given-names></string-name>, <string-name><surname>Belfield</surname> &#x000a0;<given-names>SJ</given-names></string-name>, <string-name><surname>Briggs</surname> &#x000a0;<given-names>KA</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Making in silico predictive models for toxicology FAIR</article-title>. <source><italic toggle="yes">Regul Toxicol Pharmacol</italic></source> &#x000a0;<year>2023</year>;<volume>140</volume>:<page-range>105385</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.yrtph.2023.105385</pub-id></mixed-citation></ref><ref id="R86"><label>86.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Iglesias-Molina</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Van Assche</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Arenas-Guerrero</surname> &#x000a0;<given-names>J</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The RML ontology: a community-driven modular redesign after a decade of experience in mapping heterogeneous data to RDF</article-title>. In: <italic toggle="yes">ISWC 2023, 22th International Semantic Web Confernece, 14266 Athens Greece</italic>, Greece <conf-date>Nov 2023</conf-date>, LNCS, 2023.</mixed-citation></ref><ref id="R87"><label>87.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Debruyne</surname> &#x000a0;<given-names>C</given-names></string-name>, and <string-name><surname>Van Assche</surname> &#x000a0;<given-names>D</given-names></string-name></person-group>. <article-title>The Conformance of an RML Processor Built from Scratch to Validate Specifications and Test Cases</article-title> 5th International Workshop on Knowledge Graph Construction co-located with 21th Extended Semantic Web Conference (ESWC 2024) 3718 of CEUR. In: <italic toggle="yes">Workshop Proceedings Heraklion, Greece</italic>, <conf-date>May 26-27 2024</conf-date>, 2024.</mixed-citation></ref><ref id="R88"><label>88.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Devlin</surname> &#x000a0;<given-names>Jacob</given-names></string-name>, <string-name><surname>Ming-Wei</surname> &#x000a0;<given-names>Chang</given-names></string-name>, <string-name><surname>Kenton</surname> &#x000a0;<given-names>Lee</given-names></string-name> and <string-name><surname>Kristina</surname> &#x000a0;<given-names>Toutanova</given-names></string-name></person-group>. <article-title>BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding</article-title>. In: <italic toggle="yes">North American Chapter of the Association for Computational Linguistics (2019), Proceedings of NAACL-HLT 2019, Minneapolis, Minnesota</italic>, June 2 - June 7, 2019, pp. 4171&#x02013;4186. 2019.</mixed-citation></ref><ref id="R89"><label>89.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Brown</surname> &#x000a0;<given-names>TB</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Ryder</surname> &#x000a0;<given-names>N</given-names></string-name></person-group> &#x000a0;<etal>et al.</etal> &#x000a0;<article-title>Language models are few-shot learners</article-title>. <year>2020</year>. <ext-link xlink:href="https://arxiv.org/abs/2005.14165" ext-link-type="uri">https://arxiv.org/abs/2005.14165</ext-link> (<comment>15 November 2024</comment>, date last accessed).</mixed-citation></ref><ref id="R90"><label>90.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Scalia</surname> &#x000a0;<given-names>G</given-names></string-name>
</person-group>. <part-title>Machine learning for scientific data analy-sis</part-title>. In: <person-group person-group-type="editor"><string-name><surname>Piroddi</surname> &#x000a0;<given-names>L</given-names></string-name></person-group> (ed.), <source><italic toggle="yes">Special Topics in Information Technology</italic></source>, <series><italic toggle="yes">SpringerBriefs in Applied Sciences and Technology (BRIEF-SPOLIMI)</italic></series>. <publisher-name>Cham, Switzerland: Springer</publisher-name>, 2022, <fpage>115</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="R91"><label>91.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sendak</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Sirdeshmukh</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Ochoa</surname> &#x000a0;<given-names>T</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Development and validation of ML-DQA-a machine learning data quality assurance framework for healthcare ML-DQA for healthcare ML-DQA for healthcare</article-title>. <source><italic toggle="yes">Proc Mach Learn Res</italic></source> &#x000a0;<year>2022</year>;<volume>182</volume>:<fpage>1</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="R92"><label>92.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hornb&#x000e6;k</surname> &#x000a0;<given-names>K</given-names></string-name>
</person-group>. <article-title>Current practice in measuring usability: challenges to usability studies and research</article-title>. <source><italic toggle="yes">Int J Hum Comput Stud</italic></source> &#x000a0;<year>2006</year>;<volume>64</volume>:<fpage>79</fpage>&#x02013;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijhcs.2005.06.002</pub-id></mixed-citation></ref><ref id="R93"><label>93.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bastien</surname> &#x000a0;<given-names>JMC</given-names></string-name>
</person-group>. <article-title>Usability testing: a review of some methodological and technical aspects of the method</article-title>. <source><italic toggle="yes">Int J Med Inform</italic></source> &#x000a0;<year>2010</year>;<volume>79</volume>:<fpage>e18</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">19345139</pub-id>
</mixed-citation></ref></ref-list></back></article>